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ABSTRACT
The locus coeruleus (LC) is a group of norepinephrine (NE)-containing neurons
that shows marked NE depletion when rats are exposed to uncontrollable shock. The
depletion of NE in the LC region results in an increase in burst-firing of LC neurons.
Evidence indicates that an increase in burst-firing of LC neurons results in a decrease in
motor activity. Intraperitoneal (ip) administration of lipopolysaccharide (LPS), cell wall
of gram-negative bacteria, also causes an increase in burst-firing of LC neurons,
apparently via the induction of interleukin-1 (IL-1) in the brain. Ip LPS also results in a
decrease in spontaneous motor activity in rats, a behavior that expressed in “sickness
behavior.” However, a causal relationship between an increase in burst-firing of LC
neurons and a decrease in spontaneous motor activity after ip LPS has not yet been
established. Therefore, this manuscript examines the effect of IL-1 acting within the LC
region on producing an aspect of sickness behavior - a decrease in spontaneous motor
activity — that is seen after ip LPS. We hypothesize that the decrease in spontaneous
motor activity that occurs after an injection of ip LPS is mediated by the induction of IL1 in the LC region.
Several experiments conducted measured spontaneous motor activity as affected
by 1) ip LPS, 2) LPS infused into the LC region or 3) IL-1 infused into the LC or LC
surrounding regions. A final experiment tested whether interleukin-1 receptor antagonist
(IL-lra) infused into the LC region would block the decrease in spontaneous motor
activity in response to an injection of ip LPS.

Ill

The results showed that a range of ip LPS doses (5-20 pg/kg), a range of LPS
doses (0.1-4.0 ng/rat) or a range of IL-lp doses (0.1-40 ng/rat) infused into the LC region
all decreased spontaneous motor activity in a dose-dependent manner. Unexpectedly, an
infusion of IL-ip (0.4 ng/rat) into LC surrounding regions did not significantly decrease
spontaneous motor activity differently from an infusion of IL-ip (0.4 ng/rat) into the LC
region. Finally, central IL-lra (40 pg/rat) was unable to block or affect the decrease in
spontaneous motor activity seen after an injection of ip LPS (10 pg/kg).
Collectively, the findings do not support the hypothesis that the decrease in
spontaneous motor activity that occurs after an injection of ip LPS is mediated by the
induction of IL-1 in the LC region. Although LPS infused into the LC region or IL-ip
infused into the LC region decreased spontaneous motor activity, IL-lra was unable to
block the decrease in spontaneous motor activity seen after an injection of ip LPS.
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CHAPTER ONE
Introduction
The introduction is divided into three parts. It begins by discussing the role of the
locus coeruleus (LC) in mediating behavioral effects that result from exposure of rats to
uncontrollable shock.

Then, current evidence is presented showing that sickness

behavior can be produced by lipopolysaccharide (LPS) or interleukin-1 (IL-1). Several
related topics will discuss and provide supporting evidence for the proposed hypothesis.
The final part of the introduction summarizes the project rationale, and briefly describes
the experiments that were completed.
Part I
Part I of the introduction describes the locus coeruleus. This is followed by data
showing that LC neuronal activity is regulated by noradrenergic (NE) input and that LC
neuronal activity is increased in response to uncontrollable shock in rats. Finally, part I
discusses how increased neuronal activity of the locus coeruleus affects motor activity in
rats.
The Locus Coeruleus is a Noradrenergic Structure
The LC is a small nucleus of NE-containing neurons located in the pons ventral to
the fourth ventricle (4V) and medial to the mesencephalic nucleus of the trigeminal
cranial nerve. The axons of LC-NE neurons supply over 70% of all the NE in the brain
(Dahlstrom et al., 1964; Huang et al., 1975), including almost all of the NE in the
cerebral cortex and the hippocampus (Huang et al., 1975).
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LC Neuronal Activity is Increased via “Functional Blockade” of a? Receptors in
Response to Uncontrollable Shock
The LC appears to play an important role in mediating the behavioral effects that
result from exposure of rats to uncontrollable shock (Simson et al, 1988; Weiss et ah,
1996). Exposure to uncontrollable shock causes large depletions of NE in the LC region
(Weiss et ah, 1981). Under basal conditions, terminals from NE neurons release NE in
the LC region and the NE activates adrenergic 0,2 receptors that are located on NE cell
bodies of the LC. The activation of 02 receptors results in an inhibition of LC neuronal
activity (Aghajanian et ah, 1977; Cedarbaum et ah, 1978a; Cedarbaum et ah, 1978b).
Conversely, non-activation of 0.2 receptors results in a disinhibition of LC neuronal
activity.

Specifically, large depletions of NE in the LC region, produced by

uncontrollable shock in rats, cause the release of NE in LC region to be decreased and <Xj
receptors not to be normally activated by NE, i.e. the depletion of NE “functionally
blocks” the (X2 receptors.

The functional blockade of ai receptors results in a

disinhibition of the LC, i.e. increased burst-firing (firing of several action potentials in
rapid succession) of LC neurons. Several behavioral changes are caused by increased
burst-firing of LC neurons, one of which is decreased motor activity (Simson et ah,
1988).
LC Alpha? Receptors Affect Motor Activity in Rats
Alpha? Receptor Antagonists Decrease Motor Activity in Rats
Exposure to uncontrollable shock depletes NE in the LC region, functionally
blocks a .2 receptors, and increase burst-firing o f LC neurons, resulting in decreased motor
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activity [measured by spontaneous motor activity (Weiss et al., 1980) or by a swim test
(Simson et al., 1988)]. In nonstressed rats, an 0,2 receptor antagonist (idazoxan) injected
intravenously (Simson et al., 1987; Simson et al., 1989) or microinfused into the LC
region (Simson et al., 1987) increased burst-firing of LC neurons, as seen after
uncontrollable shock.

Microinfusions of other a 2 receptor antagonists, such as

piperoxane or yohimbine, into the LC region of nonstressed rats, also resulted in
decreased motor activity (Weiss et al., 1986). These findings suggest that functionally
blocking LC a 2 receptors by the depletion of NE, caused by uncontrollable shock or by
administration of a 2 receptor antagonists, decreases motor activity in rats.
Activation of LC a? Receptors Blocks Decreased Motor Activity in Stressed Rats
Simson, Weiss, Ambrose, & Webster (1986a) found that decreased motor activity
in rats exposed to uncontrollable shock could be blocked by an infusion of a monoamine
oxidase inhibitor (MAOI) into the LC region. A MAOI inhibits the degradation of NE.
Immediately following uncontrollable shock, rats were infused with pargyline (a MAOI)
or a vehicle into the LC region. Motor activity, measured by a swim test, and NE
concentrations in the LC region were measured two hours post-infusion of pargyline or
vehicle. Stressed rats infused with a vehicle showed decreased motor activity and
decreased NE concentrations in the LC region, when compared to unstressed rats. In
contrast, stressed animals infused with pargyline (a MAOI) did not show a decrease in
motor activity or a decrease in NE concentrations in the LC region. Pargyline was able to
prevent the depletion of NE, normally seen after uncontrollable shock, resulting in motor
activity scores similar to those of unstressed rats (Simson et al., 1986a).
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Microinfusions of clonidine (ct2 receptor agonist) into the LC region also blocked
the decreases in motor activity seen after uncontrollable shock (Simson et al., 1986b).
Rats were exposed to either uncontrollable shock or no-shock and then returned to their
home cages for 70 minutes. After the shock or no-shock session, the rats were infused
with clonidine (ot2 receptor agonist) or a vehicle into the LC region.

Immediately

following the infusion, motor activity was measured using a swim test. Stressed rats
infused with a vehicle showed decreased motor activity, when compared to nonstressed
rats.

In contrast, stressed rats infused with clonidine did not show decreased motor

activity. The reactivation of 0,2 receptors in the LC region with clonidine resulted in
normal motor activity, similar to nonstressed rats infused with a vehicle (Simson et al.,
1986b).
In summary, a 2 receptor antagonists infused into the LC region results in
decreased motor activity of the rat. Conversely, 0,2 receptor agonists into the LC region
blocked the decrease in motor activity normally seen after exposure to uncontrollable
shock. Collectively, these results suggest that decreases in motor activity are mediated
via “functional blockade” of a .2 receptors located on NE neurons of the LC.
Part II
Part II of the introduction begins by discussing the behavioral similarities between
the effects of human depression, exposure to uncontrollable shock in rats, bacterial
infection in humans, and bacterial infection in rats. It is followed by a discussion of the
physiological and behavioral effects that result from the administration of LPS, a specific
bacterial derivative.

The effects that are caused by LPS collectively can be termed
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“sickness behavior,” and these effects are mediated by IL-1.

Evidence is presented

showing that LPS causes the induction of IL-1. General information regarding the IL-1
system is presented prior to discussing how IL-1 also causes sickness behavior as seen
after LPS.

Finally, current evidence is presented showing that both LPS and IL-1

increase LC neuronal activity, as seen after exposure to uncontrollable shock.
Uncontrollable Shock. Bacterial Infections, and Sickness Behavior Result in Similar
Behavioral Effects
Behavioral Effects of Depression, Uncontrollable Shock or Bacterial Infections
Human depression is delineated by some of the following symptoms: loss of
appetite, change in sleep pattern, decrease in body weight (or a change in body weight),
decrease in sex drive, decrease in energy levels, feelings of worthlessness, and recurrent
thoughts of suicide (American Psychiatric Association: Diagnostic and Statistical Manual
of Mental Disorders. 1994, p. 320-327). Behaviors produced by exposure of rats to
uncontrollable shock include: decreased social activities, decreased food and water
intake, decreased body weight, and decreased motor activity (Weiss et al., 1982; Weiss et
ah, 1985).

Bacterial infections also cause some of the symptoms seen after

uncontrollable shock. Bacterial meningitis in humans has shown to cause weakness
(Wispelwey et ah, 1990). Peptidoglycan, a bacteria derived from Neisseria gonorrhoeae,
causes significant decreases in food intake (Biberstine et ah, 1996). It appears that
depression in humans, exposure of rats to uncontrollable shock, and bacterial challenges
all are characterized by similar behavioral changes.
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Effects of LPS: Sickness Behavior
LPS, the outer lipid membrane of gram-negative bacteria derived from
Escherichia coli, is a large molecule that does not cross the blood brain barrier (BBB)
(Schmahl et al., 1974).

LPS injected ip causes several behavioral changes that

collectively can be termed “sickness behavior”. Sickness behavior can be defined as a
collection of physiological and behavioral changes that occur in response to an infectious
substance being introduced into the body. Some of the physiological changes caused by
LPS include: fever (Kozak et ah, 1994; Kozak et ah, 1995; Luheshi et ah, 1996; Miller et
ah, 1997), increased plasma corticosterone (Dunn., 1992)(Jones et ah, 1958)(Melby et ah,
1960)(Wexler et ah, 1957) as cited in (Dunn., 1992), and increased central interleukin-1
(IL-1) (Maier et ah, 1993; Quan et ah, 1994; Quan et ah, 1997; Van Dam et ah, 1995).
Specifically, LPS causes a large increase in IL-1 P mRNA (Ilyin et ah, 1998) for
prolonged periods followed by the direct translation into bioactive IL-1 P (Dinarello.,
1994). Among the behavioral changes caused by LPS are anhedonia [characterized by
decreased preference for a saccharin solution in fluid-deprived rats (Yirmiya., 1996)],
increased pain sensitivity [hyperalgesia (Maier et ah, 1993; Walker et ah, 1996a; Walker
et ah, 1996b; Watkins et ah, 1994a; Watkins et ah, 1994b; Watkins et ah, 1994c)],
decreased food intake (Aubert et ah, 1997; Bret-Dibat et ah, 1997a; Bret-Dibat et ah,
1997b; Ilyin et ah, 1998; Kent et ah, 1996), and decreased social exploration (Bluthe et
ah, 1992; Bluthe et ah, 1994). LPS given ip also decreases spontaneous motor activity in
mice (Kozak et ah, 1994; Kozak et ah, 1995; Laye et ah, 1995) and in rats (West, C. K. &
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Weiss, J. M., unpublished results). The primary dependent measure and the main focus
of interest throughout this manuscript is dark period spontaneous motor activity in rats.
Central and Peripheral Induction of IL-1 in Response to LPS
Infection or inflammation causes an immune response.

Among the immune

responses to an endotoxin such as LPS is the expression of in vitro and in vivo IL-1 in the
periphery and in the brain.

In vitro studies have shown that LPS stimulates the

production of IL-1 (Fontana et al., 1982; Loughlin et al., 1996) and IL-1 mRNA in
macrophages (Hetier et al., 1988; Loughlin et al., 1996).

LPS also stimulates the

production of IL-1 and IL-1 mRNA in cultured microglia (Fontana et al., 1982; Guilian et
al., 1986; Hetier et al., 1988; Loughlin et al., 1996).
In vivo studies show that ip LPS increases IL-1(3 plasma levels and increases the
expression of IL-1 P mRNA in mouse brain (Laye et al., 1995).

LPS increased

immunoreactive IL-1 (irIL-1) produced by microglial cells and IL-1 mRNA in rat brain
as soon as 30 minutes post-injection.

The induction of irIL-1 and IL-1 mRNA, in

response to LPS, was found in the meninges, choroid plexus, and circumventricular
organs (Buttini et al., 1995; Quan et al., 1997; Van Dam et al., 1995; Van Dam et al.,
1992).

The induction of brain IL-1 in response to LPS occurred whether LPS was

administered centrally or peripherally (Quan et al., 1994; Weiss et al., 1994).
LPS-Sickness Behavior may be Caused by IL-1
Several researchers suggest that IL-1 mediates the physiological and behavioral
effects of LPS. This is supported by the following results: 1) LPS causes the expression
of IL-1 in the brain (Quan et al., 1994; Weiss et al., 1994), 2) ip LPS causes a greater
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febrile response in normal mice than in IL-ip-deficient mice (Kozak et al., 1995), 3) an
interleukin-1 receptor antagonist (IL-lra) decreased the magnitude and delayed the onset
of fever produced by ip LPS (Luheshi et ah, 1996) or by LPS given subcutaneously
(Miller et ah, 1997), 4) IL-lra blocked the hyperalgesic response normally seen after LPS
(Maier et ah, 1993), and 5) administration of IL-lra blocked the decrease in social
exploration normally seen after ip LPS (Bluthe et ah, 1992).
Interleukin-1. Interleukin-1 Receptor Antagonist, and Interleukin-1 Receptors
IL-1 is a cytokine that responds to infections or inflammations, and it is found
both in the periphery and in the brain. IL-1 is a large 17-kDa molecule that may (Banks
et ah, 1989) or may not cross the blood brain barrier (Coceani et ah, 1988). The IL-1
system contains three major components: IL-1, IL-1 receptor antagonist (IL-lra), and IL1 receptors (IL-1R) (Dinarello., 1994). IL-1 is expressed in two forms: IL -la and IL-ip,
both of which are synthesized as precursor proteins that result in IL -la and IL-1 P when
the precursors are cleaved. The IL -la precursor and the cleaved form of IL -la both are
biologically active; however, the IL-1 P precursor is not biologically active. IL-lra also is
synthesized as a precursor protein and must be cleaved prior to being secreted as
biologically active. IL-lra is an endogenous cytokine and competes with IL-1 at the level
of the IL-1R; however, binding of IL-lra to the IL-1R will not initiate a biological
response (Dinarello., 1994; Dripps et ah, 1991). There are two types of IL-1 receptors:
IL-1R type I and IL-1R type II. IL-1R type I contains a single transmembrane domain
and will transduce a signal when activated by IL -la or IL-lp. There are less than 100
IL-1R type I on most cells; however, only 2-3% of the IL-1R type I need to be occupied
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for a biological response to occur.

Although IL-1R type II also contains a single

transmembrane domain, it will bind IL-1 but the receptor will not transduce a signal. In
general, IL-1 a and IL-lra have a greater affinity for the IL-1R type I and IL-1 (3 has a
greater affinity for the IL-1R type II; however, all three forms of IL-1, (IL-1 a, IL-1 (3 or
IL-lra), will bind to both receptor types (Dinarello., 1994; Dripps et al., 1991).
Bioactive IL-1 is normally present in the cortex, diencephalon, hippocampus and
brain stem (Quan et al., 1996).

IL-1 [3 mRNA has been detected in the cortex,

hippocampus, hypothalamus, cerebellum (Ilyin et al., 1998; Ilyin et al., 1996), and brain
stem (Taishi et al., 1997).

IL-1R type I mRNA is found in the hypothalamus,

hippocampus, cortex, cerebellum, and brain stem of rats (Gayle et al., 1997b). Several
other researchers also have found IL-1R type I mRNA throughout the brain and choroid
plexus of normal rats (Ericsson et al., 1995; Farrar et al., 1987; Ilyin et al., 1998; Ilyin et
al., 1996; Wong et al., 1994; Yabuuchi et al., 1994). Although IL-1R type I mRNA is
expressed mostly in non-neuronal cells, some researchers have detected IL-1R type I
mRNA in neuron-like cells in the hypothalamus, trigeminal nucleus (Ericsson et al.,
1995), thalamic nucleus (Yabuuchi et al., 1994), hippocampus, and cerebellar cortex
(Wong et al., 1994). It should be noted that rat brain IL-IRs have only been detected at
the level of mRNA, since there are no commercially available rat IL-1R antibodies.
Although it is likely that the detection of IL-1 R mRNA is correlated with functional IL1R, the actual relationship between IL-1R type I mRNA and functional IL-1R remains to
be determined.
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IL-1 and its Role in Sickness Behavior
IL-1 causes sickness behavior and induces physiological and behavioral effects
that are similar to the behavior seen after the administration of LPS (see above). Some of
the physiological effects caused by IL-1 include: fever (Kent et al, 1992; Watkins et al.,
1995), long term peripheral immune responses (Quan et al., 1994; Sundar et al., 1989;
Weiss et al., 1994), increased plasma corticosterone (Dunn., 1988; Dunn., 1992; Weiss et
al., 1994), and large increases in central IL-1 (3 mRNA (Ilyin et al., 1996). Among the
behavioral changes caused by IL-1 are: hyperalgesia (Oka et al., 1993; Watkins et al.,
1994c), decreased social exploration (Kent et al., 1992), and decreased food intake
(Gayle et al., 1997a; Kent et al., 1992; Kent et al., 1996; Plata-Salaman et al., 1992). In
addition, IL-1(3 or IL-1[3-163-171-fragment infused into the LC caused behavioral
sedation as characterized by electrocortical recordings (De Sarro et al., 1997) or by
spontaneous motor activity (Montkowski, et al., 1997).
IL-1 Sickness Behavior can be Attenuated by IL-lra
Several researchers suggest that the physiological and behavioral effects seen
after IL-1 and/or LPS are mediated by IL-1 and the IL-1R. This is supported by the
following results:

1) IL-lra blocked or attenuated behavioral effects of ip LPS (see

above). 2) IL-lra blocked the hyperalgesic response normally seen after ventricular
infusions of IL-1 (Oka et al., 1993), 3) IL-lra attenuated the fever produced by IL-1
(Kent et al., 1992; Watkins et al., 1995), 4) IL-lra blocked the decreases in social
exploration normally seen after ip IL-1 (Kent et al., 1992), and 5) central IL-lra blocked
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the decreases in food intake normally seen after ventricular IL-1 (Kent et al., 1992; Kent
et al., 1996; Plata-Salaman et al., 1992).
LPS or IL-1 and their Effects on Neuronal Activity
LPS causes c-fos expression, a marker of neuronal activity, in several brain stem
areas including: the area postrema (AP), the nucleus of the solitary tract (NST), and the
LC (Hare et al., 1995; Sagar et al., 1995; Wan et al., 1993). Similarly, LPS and IL-1 alter
the metabolism of central NE as seen by a marked increase in the content of 3-methoxy4-hydroxyphenylethylene glycol (MHPG) (Dunn., 1988; Dunn., 1992; Kabiersch et al.,
1988; Linhorst et al., 1998). An increase in MHPG, a metabolite of NE suggests an
increase in NE neuronal activity.
LPS and IL-1 affect LC neuronal activity. IL-1 microinfused into the LC region
increased burst-firing of LC neurons (Borsody., 1996) as seen after uncontrollable shock
in rats. Ip LPS or micro infusions of LPS into the LC region also causes LC neurons to
increase their burst-firing (Borsody., 1996), similar to the effects seen after IL-1 infusions
into the LC region or the administration of uncontrollable shock in rats. The increase in
burst-firing of LC neurons after ip LPS appears to be due to the induction of brain IL-1 in
the LC region, initiated by the LPS.

This is supported by the finding that IL-lra

microinfused into the LC region blocks the increase in burst-firing of LC neurons
normally seen after an injection of ip LPS (Borsody., 1996).
The increase in LC neuronal activity seen after LPS or IL-1 is similar to the LC
response after uncontrollable stress in rats. The increase in burst-firing of LC neurons,
produced by uncontrollable shock in rats, is thought to mediate the decrease in motor
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activity as measured by a swim test. Therefore, it is possible that the increase in burst
firing of LC neurons produced by ip LPS is responsible for the decrease in spontaneous
motor activity seen after ip LPS.
Part III
Part III summarizes the introduction by discussing the role of the LC in response
to uncontrollable shock, LPS, and IL-1. Furthermore, it states the project hypothesis and
briefly describes the experiments that were completed.
Project Rationale
The LC is a group of NE-containing neurons whose axons supply over 70% of all
the NE in the brain. The LC region shows marked depletion of NE when rats are exposed
to uncontrollable shock. The depletion of NE results in a disinhibition of NE neurons of
the LC and this disinhibition is expressed as an increase in burst-firing of LC neurons.
The increase in burst-firing of LC neurons results in a decrease of motor activity in rats.
Ip LPS causes a similar increase in burst-firing of LC neurons and a decrease in
spontaneous motor activity. The increase in burst-firing of LC neurons seen after ip LPS
is likely due to the induction of IL-1 in the LC region initiated by the LPS. This is
supported by the following: 1) ip LPS causes the induction of IL-1 in the brain, 2) IL-1
microinfused into the LC region increases burst-firing of LC neurons, and 3) IL-lra
microinfused into the LC region blocks the increase in burst-firing of LC neurons
normally seen after ip LPS. However, a causal relationship between the increase in burst
firing of LC neurons after ip LPS and the decrease in spontaneous motor activity
produced by ip LPS has not yet been established. Therefore, this manuscript examines
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the effect of IL-1 acting within the LC region on producing a decrease in spontaneous
motor activity after ip LPS. We hypothesize that the decrease in spontaneous motor
activity that occurs after an injection of ip LPS is mediated by the induction of IL-1
in the LC region.
Preliminary results collected in our laboratory showed that ip LPS decreases
spontaneous motor activity in rats. Exp. 1 tests whether a range of ip LPS doses would
cause a dose-related decrease in spontaneous motor activity. Exp. 2 tests whether a range
of LPS doses infused into the LC region would decrease spontaneous motor activity in a
dose-dependent manner. LPS is administered into the LC region because previous results
indicate that ip LPS causes the induction of IL-1 in microglia and that physiological and
behavioral effects of LPS are mediated by IL-1 in the brain. Exp. 3 tests whether a range
of IL-1 doses microinfused into the LC region would decrease spontaneous motor activity
as seen after ip LPS and whether the effects of IL-1 are dose-dependent. Exp. 4 tests
whether the predicted decrease in spontaneous motor activity after an infusion of IL-1
into the LC region would be specific to the LC. This was done by assessing whether the
decrease in motor activity would occur only if IL-1 were infused into the LC region and
would not occur if IL-1 were infused into regions surrounding the LC. Exp. 5 measures
changes in food and water intake, home-cage behaviors (digging, grooming, sitting, etc.),
swim-test behaviors (struggling and floating) in addition to spontaneous motor activity in
response to IL-1 infused into the LC region. Exp. 6 tests whether IL-lra infused into the
LC region would block the expected decrease in spontaneous motor activity after ip LPS.
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CHAPTER TWO
General Methods
Procedures
Animals
Female (Exp. 1) and male (all other experiments) pathogen-free Sprague-Dawley
rats (derived from Charles River Laboratories) were selected from our group-housed
colony. Three to four month female rats weighed 200-350 grams (g) at the time of
testing; and two to six month old male rats weighed 200-650 g at the time of testing. All
animals were single housed in a room dedicated to monitoring of spontaneous motor
activity by a computer-controlled system. Animals were placed into single housing for 34 days prior to measuring dependent variables or the surgical procedure. The room
temperature was maintained at ~22°C with a 12:12 light: dark period (lights on from
0700-1900 hours (hrs.), unless noted otherwise. Purina rodent chow (No. 5001) and tap
water were provided ad libitum. Deviations from the above procedure are detailed in
their respective experimental methods section
Surgical Procedures
Animals were anesthetized with Halothane (3% in 100% oxygen, 3 liters/minute
flow rate), the fur at the top of the head was shaved, and they were placed in the
stereotaxic apparatus (David Kopf Instruments). A skin incision was made, a hole drilled
in the skull, and dura mater was exposed in order to implant the cannula. The stereotaxic
coordinates used to implant the cannulae are given in Table 1 and shown in Figure 1.
The brain regions of interest are the (AQ), the locus coeruleus (LC), medial to the
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Stereotaxic Coordinates

Structure
AQ

Nose
angle

AP (from AP (from
Lambda) Bregma
-3.3°
0 mm
-8.30 mm

ML

DV

0 mm

Approx. -5.0

LC

-10.0°

-3.6 mm

-9.30 mm +/- 1.1 mm

-7.0

m-LC

-10.0°

-3.6 mm

-9.30 mm

0 mm

-7.2

1-LC

-10.0°

-3.6 mm

-9.30 mm +/- 2.0 mm

-6.7

4V

-3.3°

-2.7 mm

-11.60 mm

0 mm

15.0° tilt a t-8.0

AP/NST

-3.3°

-4.0 mm

-13.68 mm

0 mm

15.0° tilt a t-8.0

Table 1. Stereotaxic coordinates used to implant a cannula (Paxinos & Watson, 1997).
Coordinates for the aqueduct (AQ), the locus coeruleus (LC), medial to the LC (m-LC),
lateral to the LC (1-LC), the fourth ventricle (4V), and the area postrema/nucleus of the
solitary tract region (AP/NST).
Anterior/posterior (AP) coordinates actually used are those referenced from the Lambda
intersection. Equivalent coordinates from Bregma are provided as reference points in the
stereotaxic atlas. Medial/lateral (ML) coordinates are referenced from the midline suture.
The dorsal/ventral (DV) coordinates are referenced from dura mater to the implanted tip
of the beveled cannula needle. The actual DV coordinate for the AQ was determined by
the presence of cerebral spinal fluid (CSF) in the cannula. The DV coordinate for the 4V
and the AP/NST are with the universal stereotaxic arm set at a 15° forward tilt.
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AQ, Bregma -8.30 mm
a a
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m-LC, Bregma -9.30 mm
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v / r n o j /n s

4V, Bregma -11.60 mm

Figure 1. Representative coronal view of cannulae in the AQ, LC, m-LC, 1-LC, 4V or the
AP/NST.
‘From The Rat Brain in Stereotaxic Coordinates, by G. Paxinos and C. Watson, 1997,
New York: Academic Press. Copyright © 1997 by Academic Press. Adapted with
permission by Academic Press.
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LC (m-LC), lateral to the LC (1-LC), the fourth ventricle (4V), and the area
postrema/nucleus of the solitary tract (AP/NST). Each cannula was secured to the skull
using 3/64 inches jeweler’s screws and dental acrylic. Suture silk was used to close the
skin incision made during surgery. The animals were returned to their home cage and
given a 10-12 day recovery period prior to the administration of a drug.
Handling Procedures
Prior to any experimental procedure, animals were handled for 1-2 min./day,
between 1700-1900 hrs. for a total of three days. Animals that were to receive an ip
injection were handled so that their abdomen was exposed, as would occur when
administering an ip drug. Animals that were to be infused were handled by gently
restraining them, as it would occur during the infusion procedure.

Following the

handling process, spontaneous motor activity was recorded during the dark period and a
three-day mean of motor activity was calculated. The three-day mean of motor activity is
referred to as “baseline” motor activity.

Deviations from the above procedure are

detailed in their respective experimental methods section. Baseline motor activity was
used to divide the animals into matched groups.
Spontaneous Motor Activity
In anticipation of the year 2000 and the potential computer/software problems that
might have occurred, the computer software program that monitored spontaneous motor
activity was updated after the completion of Exps. 1, 2-Part I, 3, 4 and 6. Experiments 2Part II and Exp. 5 were conducted with an updated version of the computer software that
measured spontaneous motor activity.
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General Procedures for all Experiments
Animals were single housed and spontaneous motor activity was monitored by a
computer-controlled system. The cages used while recording motor activity are standard
45 X 25 X 20 cm polycarbonate cages with wire lids. The cages contained Vi-inchcomcob bedding that was in direct contact with the animal. Spontaneous motor activity
was recorded by eight infrared beams, spaced 5 cm apart, positioned in a horizontal frame
that surrounds the home cage of the animal (ANA 1219, Riverpoint Electronics).
Spontaneous motor activity represents general horizontal motor activity of the animal and
is expressed as ambulatory counts (defined below) per hour. Repetitive movements by
the animal in the same location are not counted as spontaneous motor activity.
Spontaneous motor activity during the dark period is the primary dependent variable
measured throughout the experiments in this manuscript.
Experiments 1. 2-Part I, 3. 4 and 6
Spontaneous motor activity (ambulatory counts) was monitored by two software
programs; a DOS version of Crosstalk Script (programmed by Bob Bonsall) and a
BASIC program that connected each cage to the computer-controlled system that
calculated ambulation. A change in any of the eight infrared beams (being broken or
unbroken) was recorded as a “sentence” by the computer. Each sentence represented the
state of all eight infrared beams. Infrared beam changes were calculated by the computer
and expressed as ambulatory counts (spontaneous motor activity). An ambulatory count
was defined as a change in an infrared beam that had remained unchanged in the previous
four “sentences”.
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Experiment 2-Part II and Experiment 5
The new computer-controlled system only required one software package to
record motor activity (Labview Version 5.1 programmed by Bob Bonsall of Circular
Solutions using Windows 98 as an operating system). A change in any of the eight
infrared beams (being broken or unbroken) was recorded as a “sentence” by the new
computer software. Each sentence represented the state of all eight infrared beams.
Infrared beam changes were calculated by the computer and expressed as ambulatory
counts. The new computer software defined an ambulatory count as a change in an
infrared beam that had remained unchanged in the previous five “sentences”.
Cannula and Infusion Needle Construction
Representations of an implanted cannula, an infusion needle/tubing, an attached
microsyringe and microsyringe driver are shown in Figure 2; see Appendix A for detailed
information. Each cannula was constructed from a 26 gauge (GA) intradermal bevel
needle. The non-beveled end of the needle was attached to a narrow piece of silicone
tubing, 5 cm in length. Also attached to the non-beveled end of the needle and covering
the narrow tubing was a larger piece of silicone tubing, exactly 3.2 cm in length. To
prevent clogging of the cannula after it was implanted, an obturator was inserted into the
narrow tubing and held in place with silicone glue.
Drug delivery occurred via a stainless steel infusion needle attached to a
microsyringe driver with polyethylene (PE) tubing. The drug was loaded into the tip of
the infusion needle and the infusion needle was then inserted into the exposed portion of
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Figure 2. Representations of an implanted cannula (bottom right), an infusion
needle/tubing (left) and an attached microsyringe driver (top right).
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narrow silicone tube that was part of the implanted cannula. The microsyringe driver that
holds two lOpl Hamilton syringes, was used to measure the amount of drug infused.
Infusion Procedure
The infusion procedure began prior to lights off and occurred adjacent to the room
where motor activity was measured.

Specific times of infusion are detailed in the

respective experimental methods section. One animal at a time was transported in their
home cage to the infusion room and gently restrained. The narrow tube of each cannula
was cut flush with the end of the large silicone tube and the infusion needle was then
inserted into the narrow silicone tube of the implanted cannula; see Figure 2 and
Appendix A. The animal was returned to its home cage and remained there for the
duration of the infusion (~5 min.). During the first minute of the infusion, the drug is
advanced through a 2 pi “deadspace”. The deadspace is measured in volume and is
defined as the space between the end of the inserted infusion needle and the tip of the
implanted cannula resting in the brain. Once the drug has passed the deadspace and when
infusing a midline structure, 2 pi were infused at a rate of 500 nl/min. When infusing a
bilateral structure, 1 pl/side was infused at a rate of 250 nl/min. The infusion needle was
left in place for 30 seconds to avoid a vacuum effect upon removal. The animal was
removed from its home cage, the infusion needle was removed and the end of the
exposed silicone tubing was sealed with an electrical pin connector. The animal was
again returned to its home cage and the cage was transported back into the room where
motor activity was measured for 12 hrs. post-infusion.
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Verification of Cannula Placement
Animals were anesthetized with Halothane, decapitated, and their brains were
removed. A few brains were quickly dissected into 1 mm sections using a coronal brain
blocker and cannulae placements were noted in a written form or recorded on section
reproductions from the stereotaxic atlas. Unless noted otherwise, the majority of the
brains were post-fixed in 4% paraformaldehyde until they were cut at 120 pm on a
freezing microtome. The sections were mounted on slides, viewed under a microscope
and cannulae placements were recorded on section reproductions from the stereotaxic
atlas. Cannulae placements that were considered “misses” were omitted from statistical
analyses and data presentation, unless otherwise noted.
Drugs
Intraperitoneal procedures
Dulbecco’s phosphate buffered salt solution IX (VEH) was used as a vehicle in a
volume of 1.0 ml/kg of body weight. LPS (Sigma, L-3129) was diluted with VEH on the
day injections were given. Specific LPS doses are detailed in respective experimental
methods section.
Infusion procedures
Artificial cerebral spinal fluid (CSF) that contained 0.128M NaCl, 1.7 mM CaCl,
2.68 mM KC1 and 0.98 mM MgCl was used as a vehicle for infusions. One to two days
prior to the infusion procedure, recombinant rat interleukin-1p [(IL-1(3), R & D Systems],
interleukin-1 receptor antagonist [(IL-lra) a gift from Synergen, Inc.], LPS (Sigma, L3129) and Fluorescein Isothiocyanate LPS [(fic-LPS), Sigma, F-3540] were diluted in

23

CSF and stored at 4°C until used. Specific doses are detailed in respective experimental
methods section.
Experimental Replications
Due to the number of animals in each study, it was necessary to conduct most
experiments as a set of replications.

Each replication used the same criteria and

methodological procedures as the other replications within an experiment. In a single
experiment, each replication contains a representative sample of the different groups.
After appropriate statistical analyses, the data from each replication were combined and
treated as a single data set, unless otherwise noted.
General Statistical Analyses
Experiments E 2-Part I, 3, 4 and 6
Pre-baseline (Exp. 1) or baseline (Exps. 2-4, 6) motor activity for each experiment
was analyzed by a repeated measures analysis of variance (RM-ANOVA).

These

analyses were conducted to insure that pre-baseline (Exp. 1) or baseline (Exps. 2-4, 6)
motor activity of the different groups were not statistically different. Post-injection (Exp.
1), post-infusion (Exps. 2-4) or post-infusion/injection (Exp. 6) motor activity were
analyzed by a RM-ANOVA followed by separate two-way ANOVAs (Exp. 1) or one
way ANOVAs (Exp. 2-4, 6) at each hour of the dark period. A priori analyses were
calculated with SPSS Statistical Software V 8.2. Following the ANOVA and where
appropriate, post hoc analyses were conducted by a Dunnett test. Data are considered to
reach statistical significance if p < 0.05, unless otherwise stated and reported in
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respective results sections.

Specific statistical significance’s are reported in the

respective result section each experiment.
Experiment 2-Part II and Experiment 5
Exp. 2-Part II does not require statistical analyses.

Descriptions of the

histological data are presented in its respective results section. Statistical analyses for
Exp. 5 were calculated with SPSS Statistical Software V 8.2 (RM-ANOVAs) or Sigma
Stat for Windows V 2.0 (Two-way ANOVAs) and are detailed in its respective methods
section.
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CHAPTER THREE
Experiment 1: Intraperitoneal LPS
Rationale
Preliminary results, collected in our laboratory, have shown that ip LPS (10
pg/kg) decreases spontaneous motor activity. Exp. 1 tested whether a range of ip LPS
doses would cause dose-dependent decreases in spontaneous motor activity. Many of the
studies included in this dissertation require animals to be handled prior to the infusion
procedure. Therefore, ip LPS was given to both handled and nonhandled animals in
order to determine if the effects of ip LPS on spontaneous motor activity would differ
depending on whether animals are handled or nonhandled; see handling procedure
section in the general methods section.
Methods
Procedure
Female rats were obtained from our group-housed colony room and placed into
single housing for approximately three days prior to collecting any data. Following this
period, three days (days 1, 2 & 3) of motor activity were recorded during the dark period
of each day (1900-0700 hrs.). These three days (days 1, 2 and 3) were averaged and the
mean was used to assign the animals to two matched groups: handled and nonhandled
rats. During days 4, 5 and 6 one group of animals was handled and the remaining group
of animals was left undisturbed (nonhandled). Motor activity was recorded for both
groups during the dark period. These three days (days 4, 5 and 6) were averaged and the
mean was used to further assign animals to eight matched experimental groups (n=8-12
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per group). Each animal in the handled or nonhandled group received one the following
ip doses: control (VEH), 5 pg, 10 pg or 20 pg/ml of LPS/kg of body weight. On day
seven, ip injections were given just prior to lights out (lights out - 1900 hrs.) and motor
activity during the dark period was recorded for 12 hrs. post-injection.
Statistical Analyses
Pre-baseline motor activity (a mean of days 1, 2 & 3) was analyzed by a RMANOVA factorial design (12 [hour] X 4 [drug level] X 2 [handled/nonhandled]). Post
injection motor activity also was analyzed by 1 2 X 4 X 2 RM-ANOVA. Finally, each
hour of post-injection motor activity was analyzed by a separate two-way ANOVA (4 X
2 ).

Results
A RM-ANOVA (hour X drug level X handled/nonhandled) analyzing pre
baseline motor activity yielded a significant main effect of hour (F( 11, 858) = 25.76, p <
.001], The remaining main effects of drug level, handled/nonhandled, or any interaction
were not statistically significant. This analysis indicated that, while pre-baseline motor
activity differed depending on the hour of the dark period, there was no difference in pre
baseline motor activity between any of the groups prior to treatment or between pre
handled vs. pre-nonhandled animals at any hour.
A RM-ANOVA (hour X drug level X handled/nonhandled) analyzing post
injection motor activity yielded a significant main effect of hour [F( 11, 858) = 43.12, p <
.001], drug level [F(3, 78) = 5.05, p = .003] and handled/nonhandled [F(l, 78) = 6.29, p =
.010]. All interactions were not statistically significant. The main effect of hour was
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derived from a “U-shaped” pattern of motor activity during the dark period that was seen
in all drug levels and in both handled and nonhandled rats. The main effect of drug level
was derived from the decrease in motor activity seen after an injection of ip LPS. The
main effect of handled/nonhandled was derived from the nonhandled animals showing
slightly less motor activity than the handled animals (Figure 3 and Figure 4). It is
important

to

note

that the

three-way

interaction

(hour

X

drug

level

X

handled/nonhandled) did not reach statistical significance. This interaction tests whether
ip LPS affects handled vs. nonhandled animals differently depending on the dose of LPS
given and the hour of the dark period.
Separate two-way ANOVAs (drug level X handled/nonhandled) of post-injection
motor activity at each hour of the dark period yielded significant main effects of drug
level and handled/nonhandled at different hours (Figure 3 and Figure 4). Specifically, the
main effect of drug level was statistically significant at hour 3, 5 and 6 [F(3, 86) = 5.71,
5.30, 4.28, p = .001, .002, .008, hrs. 3, 5 & 6 respectively]. The main effect of drug level
was derived from the decrease in motor activity seen after an injection of ip LPS. The
main effect of handled/nonhandled was statistically significant at hours 2, 3 and 6 [F(l,
86) = 5.50, 5.20, 5.43, p = .022, .025, .022, hrs. 2, 3, & 6 respectively]. The main effect
of handled/nonhandled was derived from the nonhandled animals showing slightly less
motor activity than the handled animals. None of the two-way interactions at each hour
(drug level X handled/nonhandled) reached statistical significance. A significant twoway interaction would indicate whether the decrease in spontaneous motor activity in
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Intraperitoneal VEH or LPS Injections

Spontaneous Motor Activity (Ambulatory Counts/Hour)

-♦— Handled
■<>— Nonhandled

Hours Post-Injection

Hours Post-Injection

Figure 3. Mean (±SEM) ambulatory counts/hour (dark period spontaneous motor
activity) of handled or nonhandled rats injected with ip VEH or LPS (5, 10 or 20 pg/kg).
Graphs show handled and nonhandled animals at each drug level.
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Intraperitoneal VEH or LPS Injections
—•——♦——■——▲
—-

VEH
LPS (5 pg/kg)
LPS (10 pg/kg)
LPS (20 pg/kg)

n=9
n=12
n=12
n=12

—o— VEH
LPS (5 pg/kg)
LPS (10 pg/kg)
LPS (20 pg/kg)

n=8
n=l 1
n=l 1
n=l 1

U

b

0

O

Hours Post-Injection

Figure 4. Mean (+SEM) ambulatory counts/hour (dark period spontaneous motor
activity) of handled or nonhandled rats injected with ip VEH or LPS (5, 10 or 20 pg/kg).
The top graph shows handled animals at all drug levels and the bottom graph shows
nonhandled animals at all drug levels.
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response to ip LPS is different depending on whether the animals are handled or
nonhandled.
Discussion
Measurement of pre-baseline spontaneous motor activity revealed that the eight
groups began the experiment with comparable motor activity. When pre-baseline motor
activity was analyzed by a RM-ANOVA (hour X drug level X handled/nonhandled), the
significant main effect of hour during the dark period can be described by a “U-shaped”
pattern. However, the main effects of drug level and handled/nonhandled, as well as all
interactions, were not statistically significant.
A RM-ANOVA (hour X drug level X handled/nonhandled) of post-injection
motor activity yielded statistically significant main effects of hour, drug level and
handled/nonhandled. The main effects of hour and drug level can be described by a “Ushaped” pattern of motor activity during the dark period and by a decrease in spontaneous
motor activity of the animals in response to ip LPS.

The main effect of

handled/nonhandled can be described by a slightly lower amount of motor activity of
nonhandled animals when compared to the handled animals. Although these individual
main effects were found, the most important factor in this experiment is the three-way
interaction.

The three-way interaction tests whether ip LPS affects handled vs.

nonhandled animals differently depending on the dose given and the hour of the dark
period, and this interaction was not statistically significant.
Although not statistically significant, the trend for ip LPS to decrease spontaneous
motor activity occurred in a dose-dependent manner (Figure 3 & Figure 4). Specifically,
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VEH did not decrease spontaneous motor activity but the two highest doses of LPS (10 or
20 pg/kg) tended to decrease spontaneous motor activity more effectively than the lowest
dose of LPS (5 pg/kg). However, handling did not significantly affect this outcome. The
RM-ANOVA (hour X drug level X handled/nonhandled) and the separate two-way
ANOVAs (each hour, drug level X handled/nonhandled) of post-injection motor activity
indicate that ip LPS at various drug levels did not significantly decrease spontaneous
motor activity differently in the handled or nonhandled groups (Figure 3 & Figure 4).
The results from this study suggest that ip LPS does not decrease spontaneous
motor activity differently in handled or nonhandled rats.

Many of the experiments

detailed in this dissertation required animals to be handled prior to the infusion
procedures. Therefore, handling animals prior to the infusion should not significantly
alter the overall effects in response to LPS and/or “sickness behavior”. Specifically,
handling animals prior to the infusion of LPS (Exp. 2-Part I) or IL-1 (Exp. 3) should not
cause the expected decreases in spontaneous motor activity to be significantly different
from what they would be in nonhandled animals.
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CHAPTER FOUR
E x p e r im e n t 2 - P a r t I: L P S I n f u s io n s in t o t h e L C R e g io n

Rationale
Uncontrollable shock in rats causes an increase in burst-firing of LC neurons and
a decrease in motor activity. Similarly, ip LPS or microinfusions of LPS into the LC
region also causes an increase in burst-firing of LC neurons, and ip LPS decreases
spontaneous motor activity as was seen in Exp. 1. Previous findings have shown that
LPS causes the induction of IL-1 in brain microglia for prolonged periods; therefore,
prolonged activation of IL-1 receptors can be achieved by infusing LPS into the LC
region. If the activation of LC neurons is involved in decreasing spontaneous motor
activity and ip LPS has been shown to stimulate IL-1, which causes activation of LC
neurons, then an infusion of LPS into the LC region should decrease spontaneous motor
activity. Part I of Exp. 2 was to test whether LPS infused into the LC region would cause
a decrease in spontaneous motor activity. A range of LPS doses were infused to test
whether the effects on motor activity would be dose-dependent.

Part II of Exp. 2

describes the diffusion distances of Fluorescein Isothiocyanate LPS (fic-LPS, a
fluorescent LPS) from the LC region.
Part I: Methods
Surgical. Spontaneous Motor Activity, and Infusion Procedures
The procedural methods are detailed in the general methods section. Briefly,
male rats were obtained from our group-housed colony and single housed in a room
where spontaneous motor activity was monitored by a computer-controlled system. After
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several days of housing under these conditions, animals underwent surgery. The animals
were anesthetized with Halothane and implanted with a bilateral cannula aimed at the LC
region (Table 1).

Seven to ten days after surgery, spontaneous motor activity was

recorded for three days and a mean of these three days was calculated, representing
baseline motor activity for the animals. On each of these three days, the animals also
were handled. Based on their baseline motor activity, animals were assigned to six
matched groups (n=4-12 per group) and infused with CSF or varying doses of LPS (0.1,
0.2, 1, 2, or 4 ng/rat) in lpl/side of LC, for a total infusion volume of 2 pl/rat. Infusions
began one hour prior to lights out (lights out - 19:00 hrs.). After the infusion, the animals
were returned to their home cage and motor activity was recorded for 12 hrs. post
infusion during the dark period.
Statistical Analyses
Baseline motor activity was analyzed by a RM-ANOVA factorial design (12
[hour] X 6 [drug level]). Post-infusion motor activity also was analyzed by a 12 X 6 RMANOVA. Finally, each hour of post-infusion motor activity was analyzed by a separate
one-way ANOVA ( 1 X 6 [drug level]). Following separate one-way ANOVAs and
where appropriate, post hoc analyses were conducted by a Dunnett test comparing the
LPS infused groups with the CSF-infused group.
Motor activity of animals with cannulae that terminated directly in the LC and
animals with cannulae that terminated “near the LC” showed similar effects of LPS on
motor activity. Therefore, all of the animals implanted with cannulae aimed at the LC
region, with the exception of one animal, were included in the statistical analyses and
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data presentation. One animal was omitted due to the large margin by which it missed
the LC (0.5-0.6 mm medial/lateral from the LC). Representations of cannulae aimed at
the LC region are pictured in Figure 5. Two animals had cannulae placements that were
slightly anterior to the LC, as shown on a section reproduction from the stereotaxic atlas
(Figure 5, Bregma -8.8 mm). Since the width of the cannula is 0.54 mm, the bevel of the
cannulae faces caudally and the placements are sufficiently close to overlap into the first
atlas plate that contains the LC (Bregma -9.16 mm), these animals were included in
statistical analyses and data presentation. Not all of the animals are represented in Figure
5 because cannulae placements for 12 of the animals were verified and noted only in
written form. According to the written notes, all 12 placements were considered to be in
the LC region and were included in the statistical analyses and data representation.
Part I: Results
A RM-ANOVA (hour X drug level) analyzing baseline motor activity yielded a
significant main effect of hour [F(l 1, 451) = 13.82, p < .001]. The remaining main effect
of drug level and the two-way interaction were not statistically significant. This analysis
indicated that, while baseline motor activity differed depending on the hour of the dark
period, there was no difference in baseline motor activity at any hour between any of the
groups prior to treatment.
A RM-ANOVA (hour X drug level) analyzing post-infusion motor activity
yielded a significant main effect of hour [F( 11, 451) = 26.56, p < .001] and drug level
[F(5, 41) = 4.26, p = .003]. The main effect of hour is derived from a “skewed-U”
pattern of motor activity during the dark period that was seen at all drug levels, except for
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CSF animals; Bregma -9.30 mm

LPS animals; Bregma -8.8 mm

LPS animals; Bregma -9.30 mm

Figure 5. Representative coronal view of cannulae placements that were aimed at the LC
region. Top left graph shows represents cannulae placements for animals infused with
CSF. The remaining three graphs represent cannulae placements for animals infused
with LPS.
2From The Rat Brain in Stereotaxic Coordinates, by G. Paxinos and C. Watson, 1997,
New York: Academic Press. Copyright © 1997 by Academic Press. Adapted with
permission by Academic Press.
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the lowest dose of LPS (0.1 ng LPS/rat) which did not show a decrease in motor activity
over the initial hours of the dark period. The main effect of drug level was derived from
the decrease in motor activity after the animals received an infusion of LPS into the LC
region (Figure 6). The two-way interaction approached statistical significance [F(55,
451)= 1.34, e = .061].
Separate one-way ANOVAs (each hour X drug level) of post-infusion motor
activity of the dark period yielded a significant main effect of drug level at hours 3-8
[F(5, 46) - 5.18, 9.69, 6.43, 6.84, 2.89, 3.82; p = .001, < .001, < .001, < .001, = .025, =
.006, hrs. 3-8 respectively]. Dunnetf s tests performed at each hour comparing post
infusion motor activity of the LPS groups with the CSF group yielded statistically
significant differences that were time- and dose-dependent. Specifically, the lowest dose
of LPS (0.1 ng/rat) produced increased motor activity at hour eight post-infusion but did
not yield a statistically significant difference at any other hour. The second lowest dose
of LPS (0.2 ng/rat) decreased motor activity at hours three and four post-infusion. The
middle dose of LPS (1 ng/rat) and the two largest doses of LPS (2 and 4 ng/rat) decreased
motor activity from hours three to six (Figure 6).
Part I: Discussion
Measurement of baseline spontaneous motor activity revealed that the six groups
began the experiment with comparable motor activity. When baseline motor activity was
analyzed by a RM-ANOVA (hour X drug level), the significant main effect of hour
during the dark period can be described by a “skewed-U” pattern. However, the main
effect of drug level or the two-way interaction (hour X drug level) were not statistically
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CSF,
0.1 ng LPS/rat,
0.2 ng LPS/rat,
1 ng LPS/rat,
2 ng LPS/rat,
4 ng LPS/rat,

n=12
n=8
n=10
n=9
n=4
n=4

Hours Post-Infusion

Figure 6. Mean (±SEM) ambulatory counts/hour (dark period spontaneous motor
activity) of rats infused with CSF or LPS (0.1, 0.2, 1, 2 or 4 ng/rat) into the LC region.
Note that the CSF group is included in all of the graphs for easier inspection of the data.
The asterisk (*) and plus sign (+) designate a significance level of p < 0.05. * = CSF vs.
all other doses shown on that section of the figure. + = CSF vs. lng/rat of LPS.
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significant.
The RM-ANOVA analysis (hour X drug level) of post-infusion motor activity
yielded a main effect of hour and drug level, but the two-way interaction term did not
reach statistical significance. The main effect of hour indicates that spontaneous motor
activity is different across time (hours). The main effect of drug level indicates that LPS
infused into the LC region decreases spontaneous motor activity in a dose-dependent
manner. The two-way interaction (hour X drug level) was not statistically significant.
Separate Dunnetf s tests comparing post-infusion spontaneous motor activity of
the various LPS groups with the CSF group at each hour indicate that various doses of
LPS decreased spontaneous motor activity (Figure 6). Specifically, the CSF group and
the lowest dose of LPS (0.1 ng/rat) group showed similar motor activity across each hour,
except for hour eight in which 0.1 ng LPS/rat actually increased activity. The second
lowest dose of LPS (0.2 ng/rat) decreased motor activity for two hours while the middle
dose (1 ng/rat) and two highest doses of LPS (2 and 4 ng/rat) continued to affect motor
activity for a total of four hours. These results indicate that higher doses of LPS infused
into the LC region decrease spontaneous motor activity for longer periods than lower
doses of LPS.
It is noteworthy that the onset of the decrease in spontaneous motor activity
occurs at hour three post-infusion regardless of the dose of infused LPS.

Previous

findings have shown that LPS causes the induction of IL-1 in the brain. The time delay
between the infusion of LPS into the LC region and the onset of the decrease in
spontaneous motor activity may be attributable to the time needed for LPS to cause the
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induction of IL-1 in the brain. Furthermore, the onset of the decrease in spontaneous
motor activity tends to occur in an “all or nothing” manner.

This suggests that a

threshold level of LPS must be reached for the induction of IL-1 in the brain to cause the
decrease in spontaneous motor activity.
Lower doses of LPS infused into the LC region resulted in the animals recovering
from the decrease in spontaneous motor activity sooner than animals infused with higher
doses of LPS. Specifically, the group receiving the second lowest dose of LPS (0.2
ng/rat) recovered from the decrease in spontaneous motor activity two hours sooner than
the groups receiving the three highest doses of LPS (1,2 and 4 ng/rat). The difference in
recovery time from decreased motor activity may be a dose-dependent effect of the LPS,
suggesting that higher doses of LPS possibly maintain the induction of IL-1 for longer
periods than lower doses of LPS.
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E x p e r im e n t 2 -P a r t II: F ic -L P S D iff u s io n fr o m t h e L C R e g io n

Rationale
Part II of Exp. 2 describes the diffusion characteristics of Fluorescein
Isothiocyanate LPS (fic-LPS, a fluorescent LPS) from the LC region.

This was

accomplished by infusing fic-LPS into the LC region and measuring diffusion distances
of fic-LPS from the infusion site. Since fic-LPS is LPS that is labeled with a fluorescein,
then the diffusion characteristics for both compounds should be similar.
Part II: Methods
Surgical Spontaneous Motor Activity, and Infusion Procedures
Surgical and infusion procedural methods are similar to those described in Part I
of Exp. 2 and are detailed in the general methods section. Spontaneous motor activity
procedural methods are similar as in Part I of Exp. 2 except for slight modifications that
were incorporated into the new computer software and are detailed in the general
methods section.
Briefly, male rats were obtained from our group-housed colony and single housed
in a room where spontaneous motor activity was monitored by a computer-controlled
system.

After several days of housing under these conditions, animals underwent

surgery. The animals were anesthetized and implanted with a bilateral cannula aimed at
the LC region (Table 1). Seven to ten days after surgery, spontaneous motor activity was
recorded for two days and a mean of these two days was calculated, representing baseline
motor activity for the animals. On each of these two days, the animals also were handled.
Based on their baseline motor activity, animals were assigned to two matched conditions
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(n~2 per condition) that would be killed at different times after the infusion. In one
condition the animals were killed one hour post-infusion (referred to as the “1-hour
condition”) and the other condition the animals were killed 22 hours post-infusion
(referred to as the “22-hour condition). Both conditions were infused with 4 ng/rat of ficLPS in a total volume of 2 pl/rat. Infusions began one hour prior to lights out (lights out
- 19:00 hrs.). After the infusion, the animals were returned to their home cage and motor
activity was recorded for 12 hrs. post-infusion during the dark period, only for the 22hour condition.
Histology
Animals were anesthetized with Halothane and killed at 1 or 22 hours post
infusion. Fresh brain tissue was quickly removed and placed on dry ice. The LC region
and ±2 mm were cut at 50 pm on a cryostat and alternating sections were mounted on
clean slides.

The sections that contained the cannula tract were viewed under a

fluorescent microscope and the beginning, the end, and the center of the infusion were
identified. The coronal section with the center of the infusion was photographed at a
magnification of 25 by IX, and a three dimensional diffusion distance of fic-LPS was
measured. The anterior-posterior distance covered by fic-LPS was calculated by the
number of coronal sections in which fic-LPS was visible (50 pm/section). The mediallateral and dorsal-ventral distances were calculated by measuring the width and height of
visible fic-LPS using the line tool in Image Pro Express (Version 4).
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Part II: Results
Baseline motor activity during the dark period is plotted with its respective post
infusion motor activity for each animal and are shown in Figure 7. An inspection of the
graphs for both animals show a pronounced decrease in motor activity after the animals
were infused with 4 ng/rat of fic-LPS into the LC region. The decrease in motor activity
is clearly seen when post-infusion motor activity is plotted against each animal’s own
baseline motor activity. An infusion in both animals of fic-LPS decreased motor activity
from hours 2-10 post-infusion.
Photographs of coronal sections showing the spread and shape of fic-LPS
diffusion are shown in Figure 8. The 1-hour condition showed fic-LPS in both sides of
the LC region. The diffusion distances of fic-LPS for the left and right sides were
measured and an average was calculated for anterior-posterior, medial-lateral and dorsalventral (Figure 8, left side of page). For one animal, average distances of diffusion from
the center of the infusion site of fic-LPS were 700 pm anterior-posterior, 210 pm mediallateral and 480 pm dorsal-ventral. For the other animal, average distances of diffusion
from the center of the infusion site of fic-LPS were 250 pm anterior-posterior, 185 pm
medial-lateral and 295 pm dorsal-ventral (stained photographs not shown).
Diffusion distances of fic-LPS for the 22-hour condition were much smaller than
the 1-hour condition. For one animal in the 22-hour condition, the fic-LPS infusion only
of the left side covered a distance of 100 pm anterior-posterior, 190 pm medial-lateral
and 180 pm dorsal-ventral (Figure 8, right side of page). The infusion on the right side of
the same animal was only visible in one section. The remaining animal in the 22-hour
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• A " Baseline
— — Post-Infusion

Spontaneous Motor Activity (Ambulatory Counts/Hour)

Animal #1

■■■a--- Baseline
—■— Post-Infusion

Hours (Dark Period)

Figure 7. Ambulatory counts/hour (dark period spontaneous motor activity) of individual
rats not infused (baseline) or infused with Fluorescein Isothiocyanate LPS (4 ng/rat) into
the LC region and killed 22 hours post-infusion.
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Bregma-10.30 mm

Bregma - 9.80 mm

Left ( 1-hour condition)

Left (22-hour condition)

Right (1-hour condition)

Right (22-hour condition)

Figure 8. Stained photographs showing the center of the infusion site for both left and
right sides of the LC region for individual animals infused with 4 ng/rat of fic-LPS.
The two graphs shown at the top are section reproductions from the stereotaxic atlas.
Arrows labeled LC point to the LC region. Rectangular boxes correspond to the fields
shown in the photographs directly below. The full length of the scale shown in the
bottom right photograph equals 200 pm and applies to all photographs on the page.
4From The Rat Brain in Stereotaxic Coordinates, by G. Paxinos and C. Watson, 1997,
New York: Academic Press. Copyright © 1997 by Academic Press. Adapted with
permission by Academic Press.
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condition showed fic-LPS only in a very small area on the left side and none on the right
side of the LC region (stained photographs not shown).
Part II: Discussion
Fic-LPS into the LC region decreased spontaneous motor activity (Figure 7) of
the 22-hour condition. These decreases are similar to the decreases seen after an infusion
of LPS into the LC region (Exp. 2-Part I). The decreases in spontaneous motor activity
began two hours post-infusion of fic-LPS and the effects continued for a total of nine
hours. Similar decreases would have been expected from the animals that also were
infused with fic-LPS but were killed one hour post-infusion.
Visible fluorescence of fic-LPS in the 22-hour condition was much smaller than
the fluorescence of fic-LPS in the 1-hour condition. The indication that the fic-LPS
infused into the 22-hour condition covered a smaller distance than in the 1-hour condition
may be due to the fic-LPS diffusing away from the original site of infusion.

The

prolonged time allotted for the fic-LPS to diffuse in the 22-hour condition could result in
less fluorescence at the infusion site. However, visible fluorescence of fic-LPS in both
conditions remained within 500 microns anterior-posterior, medial-lateral or dorsalmedial from the center of the infusion site. This suggests that an infusion at a distance
greater than 0.5 mm from the LC (in a three dimensional plane) could be used to test the
specificity of the LC in responding to a drug as was done in Exp. 4 and Exp. 6.
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CHAPTER FIVE
E x p e r im e n t 3 : I L - i p I n f u s io n s in t o t h e L C R e g io n

Rationale
Exposure of rats to uncontrollable shock causes an increase in burst-firing of LC
neurons, resulting in a decrease in motor activity. Similarly, ip LPS increases burst-firing
of LC neurons and decreases spontaneous motor activity. As stated in the introduction,
the increase in burst-firing of LC neurons after ip LPS appears to be mediated by IL-1 in
the brain. Therefore, the purpose of Exp. 3 was to test whether IL-1 [3 microinfused into
the LC region would decrease spontaneous motor activity as seen after ip LPS, thereby
suggesting that ip LPS acts by stimulating IL-1 in the LC region. This was accomplished
by infusing a range of IL-1 p doses into the LC region to determine if IL-1 p causes dosedependent decreases in spontaneous motor activity. The IL-ip dose-response curve also
will determine the smallest effective dose that reliably results in a decrease in
spontaneous motor activity. The smallest effective dose of IL-1p was then infused into
the LC region and LC surrounding regions to determine specificity of IL-1 action (Exp.
4) and to measure changes in general behaviors that are produced by an infusion IL-1 into
the LC region (Exp. 5).
Methods
Surgical. Spontaneous Motor Activity, and Infusion Procedures
The procedural methods are similar to Exp. 2 and are detailed in the general
methods section. Briefly, male rats were obtained from our group-housed colony and
single housed in a room where spontaneous motor activity was monitored by a computer-
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controlled system.

After several days of housing under these conditions, animals

underwent surgery. The animals were anesthetized with Halothane and implanted with a
bilateral cannula aimed at the LC (Table 1). Seven to ten days after surgery, spontaneous
motor activity was recorded for three days and a mean of these three days was calculated,
representing baseline motor activity for the animals. On each of these three days, the
animals also were handled.

Based on their baseline motor activity, animals were

assigned to six matched groups (n=3-7 per group) and infused with CSF or varying doses
of IL-ip (0.1, 0.2, 0.4, 4.0, 40 ng/rat) in 1 pl/side of LC, for a total infusion volume of 2
pl/rat. Infusions began 30 min. prior to lights out (light out - 19:00 hrs.). After the
infusion, the animals were returned to their home cage and motor activity was recorded
for 12 hrs. post-infusion during the dark period.
Statistical Analyses
Baseline motor activity was analyzed by a RM-ANOVA factorial design (12
[hour] X 6 [drug level]). Post-infusion motor activity was analyzed by a 12 X 6 RMANOVA. Finally, each hour of post-infusion motor activity was analyzed by a separate
one-way ANOVA ( 1 X 6 [drug level]).

Following each of the separate one-way

ANOVAs at each hour and where appropriate, post hoc analyses were conducted by a
Dunnett test comparing the IL-1 -infused groups with the CSF-infused group.
Results
A RM-ANOVA (hour X drug level) analyzing baseline motor activity yielded a
significant main effect of hour (F( 11, 275) = 23.42, p < .001], The remaining main effect
of drug level and the two-way interaction were not statistically significant. This analysis
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indicated that, while baseline motor activity differed depending on the hour of the dark
period, there was no difference in baseline motor activity at any hour between any of the
groups prior to treatment.
A RM-ANOVA (hour X drug level) analyzing post-infusion motor activity
yielded a main effect of hour [F( 11, 275) = 16.41, p < .001] and drug level [F(5, 25) =
3.6, p = .013]. The main effect of hour was derived from a rise in motor activity toward
the end of the dark period. The main effect of drug level was clearly derived from a
decrease in motor activity after an infusion of IL-1 (3 into the LC region. The two-way
interaction (hour X drug level) was not statistically significant.
Separate one-way ANOVAs (each hour X drug level) of post-infusion motor
activity of the dark period yielded a significant main effect of drug level from hours 3-7
[F(5, 30) = 5.28, 6.78, 3.62, 2.71, 6.52; p = .002, < .001, = .013, = .044, = .001, hrs. 3-7
respectively]. Dunnett’s tests performed at each hour comparing post-infusion motor
activity of the IL-ip-infused groups with the CSF-infused group yielded statistically
significant differences that were time- and dose-dependent (Figure 9). Specifically, the
two lowest doses of IL-lp (0.1 and 0.2 ng/rat) did not significantly decrease motor
activity at any hour. The middle dose of IL-lp (0.4 ng/rat) significantly decreased motor
activity at hour four and the second highest dose of IL-lp (4 ng/rat) decreased motor
activity at hours 3-5. The highest dose of IL-ip (40 ng/rat) decreased motor activity at
hours 3-5 and hour 7 (Figure 9).
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Hours Post-Infusion
Figure 9. Mean (±SEM) ambulatory counts/hour (dark period spontaneous motor
activity) of rats infused with CSF or IL-ip (0.1, 0.2, 0.4, 4.0 or 40 ng/rat) into the LC
region.
Note that the CSF group is included in all of the graphs for easier inspection of the data.
The asterisk (*) and plus sign (+) designate a significance level of p < 0.05. * = CSF vs.
all other doses shown on that section of the figure. + = CSF vs. the highest dose shown
on that section of the figure.
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Discussion
Measurement of baseline spontaneous motor activity revealed that the six groups
began the experiment with comparable motor activity. When baseline motor activity was
analyzed by a RM-ANOVA (hour X drug level), the significant main effect of hour
during the dark period can be described by a rise in motor activity toward the end of the
dark period. However, the main effect of drug level and the two-way interaction (hour X
drug level) were not statistically significant.
The RM-ANOVA analysis (hour X drug level) of post-infusion motor activity
yielded a main effect of hour and drug level. The main effect of hour indicates that
spontaneous motor activity is different across time (hours). The main effect of drug level
indicates that IL-ip infused into the LC region decreases spontaneous motor activity in a
dose-dependent manner.

The two-way interaction (hour X drug level) was not

statistically significant.
Separate Dunnett’s tests comparing post-infusion spontaneous motor activity of
the various IL-ip-infused groups with the CSF-infused group at each hour indicate that
various doses of IL-ip decreased spontaneous motor activity in a time- and dosedependent manner (Figure 9).

Specifically, the two lowest doses of IL-lp did not

significantly decrease spontaneous motor activity. The middle dose of IL-ip (0.4 ng/rat)
decreased spontaneous motor activity at the third hour post-infusion. The two highest
doses of IL-ip (4, 40 ng/rat) decreased spontaneous motor activity for a total of three and
four hours respectively and did so in a more pronounced manner than the middle dose of
infused IL-ip (0.4 ng/rat). These results indicate that higher doses of IL-ip infused into
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the LC region decrease spontaneous motor activity for longer periods than lower doses of
IL-ip.
A secondary purpose of this experiment was to determine the smallest effective
dose of IL-ip that resulted in a reliable decrease in spontaneous motor activity; therefore,
a range of IL-ip doses were infused into the LC region.

When separate one-way

ANOVAs (each hour X drug level) of post-infusion motor activity were followed by
Dunnett’s tests the smallest dose of IL-ip that was significantly different from the CSFinfused group was the 0.4 ng of IL-lp /rat. Statistical analyses indicate that the 0.4 ng of
IL-ip /rat is the smallest effective dose of IL-ip.
In addition to the information obtained from the statistical analyses described
above, supporting evidence can be obtained from separately reviewing the data at each
drug level.

Each section of Figure 10 shows post-infusion motor activity with its

corresponding baseline motor activity at each drug level. Inspection of the graphs shows
that the two lowest doses of IL-ip (0.1, 0.2 ng/rat) decreased spontaneous motor activity
for approximately two hours during the early portion of the dark period. The middle dose
of IL-ip (0.4 ng/rat) decreased motor activity for what appeared to be five hours across
the dark period. The two highest doses of IL-ip (4 and 40 ng/rat) decreased motor
activity for approximately seven and 11 hours across the dark period, respectively.
Furthermore, the graphs show that the 0.4 ng IL-ip/rat group affects motor activity for a
longer period of time and the effect is more pronounced than the two lowest doses of ILip (0.1, 0.2 ng/rat). The effects of the 4 ng IL-ip/rat are even longer and more
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Figure 10. Mean (±SEM) ambulatory counts/hour (dark period spontaneous motor
activity) of rats that have not been infused (baseline) and of rats infused (post-infusion)
with CSF or IL-ip (0.1, 0.2, 0.4, 4 or 40 ng/rat) into the LC region.
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pronounced than the 0.4 ng IL-ip/rat group. Finally, the effects of the highest dose of
IL-ip (40 ng/rat) extend across an 11 hour period and are even more robust than any
other dose of infused IL-ip. The results obtained from both the statistical analyses and
visually inspecting the data at each drug level indicate that the 0.4 ng of IL-lp /rat is the
smallest effective dose of IL-IP; therefore, this dose of IL-ip (0.4 ng/rat) was chosen to
conduct Exp. 4 and Exp. 5.
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CHAPTER SIX
E x p e r im e n t 4 . I L - i p I n f u s io n s in t o t h e L C a n d L C S u r r o u n d in g R e g io n s

Rationale
Exp. 4 tested whether the predicted decrease in spontaneous motor activity after
an infusion of IL-lp into the LC region is specific to the LC. This was done by assessing
whether the decrease in motor activity would occur only if IL-ip were infused into the
LC region and would not occur if IL-ip were infused into LC surrounding regions. The
dose of IL-ip used in this experiment was based on results from Exp. 3 in which 0.4 ng
of IL-ip/rat infused into the LC region caused a statistically significant decrease in
spontaneous motor activity.
Originally, six original brain regions were chosen for this experiment. The LC
was chosen as the main region of focus. The next four regions were chosen based on
their proximity to the LC and for the potential of these regions to be affected when IL-ip
is infused into the LC region. The four regions are as follows: 1) lateral to the LC (1-LC),
2) medial to the LC (m-LC), 3) the aqueduct (AQ), and 4) the fourth ventricle (4V). The
two latter regions are part of the ventricular system and an infusion of IL-ip into the LC
region could result in the diffusion of IL-lp into the ventricular system. The sixth region,
the area postrema/nucleus of the solitary tract (AP/NST) was chosen based on the
potential of the AP to receive the LPS signal when an injection of ip LPS is given. The
AP is a circumventricular organ that projects to the LC via the NST (Luppi et al., 1995).
Circumventricular organs lack the BBB and the ip LPS signal could reach the brain via
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the AP. It is possible that the AP/NST functions concurrently with the LC to cause a
decrease in spontaneous motor activity after ip LPS.
After the completion of the experiment, a seventh brain region was added.
Cannula placements verified that some cannulae were dorsomedial to the LC and
terminated in the fourth ventricle. A representative cannula is shown in Figure 11.

Figure 11. A representative coronal view (Bregma - 9.30 mm) of a cannula terminating
dorsomedial to the LC (dm-LC).
3From The Rat Brain in Stereotaxic Coordinates, by G. Paxinos and C. Watson, 1997,
New York: Academic Press. Copyright © 1997 by Academic Press. Adapted with
permission by Academic Press.
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Methods
Surgical Procedure
The procedural methods are similar to Exps. 2 and 3 and are detailed in the
general methods section. Briefly, male rats were obtained from our group-housed colony
and single housed in a room where spontaneous motor activity was monitored by a
computer-controlled system.

After several days of housing under these conditions,

animals underwent surgery.

The animals were anesthetized with Halothane and

implanted with a bilateral cannula aimed at the LC or 1-LC or a unilateral cannula aimed
at the m-LC, AQ, 4V, or the AP/NST [n=4-9 per group, (Table 1)]. The dm-LC group
was added when cannulae placement verification confirmed that several animals had
cannulae that were dorsomedial to the LC and terminated in the fourth ventricle.
The DV coordinate (Table 1) for the AQ is variable (approximately -5.0 DV)
because permanent placement of the AQ cannula is determined at the time of surgery by
the presence of CSF in the cannula. CSF rising through the cannula is indicative that the
cannula is correctly positioned within the ventricular system.

After implanting and

securing the cannula, an obturator (a thin piece of nylon) was placed inside the cannula
and the cannula was sealed with an electrical pin connector. Although some animals
were implanted with a cannula aimed at the 4V, the pressure exerted by endogenous CSF
at that point is generally not sufficient to cause the CSF to flow upward through the
cannula. Therefore, cannulae aimed at the 4V have predetermined coordinates (Table 1).
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Spontaneous Motor Activity and Infusion Procedures
Seven to ten days after surgery, spontaneous motor activity was recorded. The
procedural methods are similar to Exp. 2 and 3 and are detailed in the general methods
section. Briefly, spontaneous motor activity was recorded for three days and a mean of
these three days was calculated, representing baseline motor activity for the animals. On
each of these three days, the animals also were handled. Based on cannula location,
animals were assigned to six groups (n=4-9 per group). As stated earlier, a seventh group
was added based on cannula location and after completing the experiment. All of the
animals were infused with 0.4 ng IL-ip/rat in a total infusion volume of 2 pi. Infusions
began one hour prior to lights out (lights out - 19:00 hrs.). After the infusion, the animals
were returned to their home cage and motor activity was recorded for 12 hrs. post
infusion during the dark period.
Statistical Analyses
Baseline motor activity was analyzed by a RM-ANOVA factorial design (12
[hour] X 7 [brain region]). Post-infusion motor activity was also analyzed by a similar 12
X 7 RM-ANOVA. Finally, each hour of post-infusion motor activity was analyzed by a
separate one-way ANOVA (1 X 7).
Results
A RM-ANOVA (hour X brain region) analyzing baseline motor activity yielded a
main effect of hour (F(l 1, 473) = 17.16, p < .001]. The remaining main effect of brain
region and the two-way interaction were not statistically significant.

This analysis

indicated that, while baseline motor activity differed depending on the hour of the dark
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period, there was no difference in baseline motor activity at any hour between any of the
brain region groups.
A RM-ANOVA (hour X brain region) analyzing post-infusion motor activity
yielded a main effect of hour [F(l 1, 473) = 20.63, p < .001] which was derived from a
wide-U” pattern of activity during the dark period (Figure 12). The remaining main
effect of brain region and the two-way interaction were not statistically significant. A
significant two-way interaction would indicate that IL-lp decreases spontaneous motor
activity in a time-dependent and brain region-dependent manner.

Separate one-way

ANOVAs (each hour X brain region) of post-infusion motor activity of IL-1 {3 also did not
yield statistically significant effects at any hour.
Discussion
Measurement of baseline spontaneous motor activity revealed that the seven
groups began the experiment with comparable motor activity. When baseline motor
activity was analyzed by a RM-ANOVA (hour X brain region), the significant main
effect of hour during the dark period can be described by a “wide-U” pattern. However,
the main effect of drug level and the two-way interaction were not statistically
significant.
The RM-ANOVA analysis (hour X brain region) of post-infusion motor activity
only yielded a main effect of hour. The main effect of hour indicates that spontaneous
motor activity is different across time (hours), and was derived from the “wide-U” pattern
of motor activity during the dark period. Although a main effect of hour was found, the
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Figure 12. Mean (±SEM) ambulatory counts/hour (dark period spontaneous motor
activity) of rats infused with IL-lp (0.4 ng/rat) into the LC region and LC surrounding
regions.
Note that the LC group is included in all of the graphs for easier inspection of the data.
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most important factor in this experiment is the two-way interaction, and it was not
statistically significant. A statistically significant two-way interaction with respect to
post-infusion motor activity would indicate that IL-1(3 decreased spontaneous motor
activity differently across the hours of the dark period depending on the brain region
infused. This is confirmed by separate one-way ANOVAs at each hour.
As the statistical analyses described in the previous paragraph indicate,
spontaneous motor activity in response to an infusion of IL-ip was similar across all
brain regions including the LC region. Inspection of Figure 12 shows that IL-1(3 infused
into all of these brain regions appears to have decreased motor activity beginning at hour
two and continuing through hour five post-infusion. To assess whether motor activity
was indeed decreased by an infusion of IL-ip, a new RM-ANOVA was conducted
adding a control group that showed normal activity (i.e., no decrease) - the group from
Exp. 3 that received CSF into the LC region. The new RM-ANOVA (12 [hour] X 8
groups [7 brain regions and the LC-CSF group]) analyzing post-infusion motor activity
yielded a main effect of hour [F( 11, 517) = 21.14, p < .001], However, the remaining
main effect of groups and the two-way interaction were not statistically significant.
Additionally, separate one-way ANOVAs (each hour X groups [7 brain regions and the
LC-CSF group]) also did not show a statistically significant effect of group at any hour.
These results indicate that, in the present experiment, infusion of IL-1P did not produce a
statistically significant decrease in spontaneous motor activity. Based on the results that
were obtained in Exp. 3, 0.4 ng of IL-ip/rat was chosen for use in the study described
here because this was found to be the lowest dose of IL-1p that caused a statistically
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significant decrease in motor activity. It is unclear why 0.4 ng of IL-ip/rat did not yield
a statistically significant decrease in motor activity in the present experiment, at least
when infused into the LC region.
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CHAPTER SEVEN
Experiment 5: Effects of IL-1(3 Infusions into the LC Region on Various Behaviors
Rationale
Experiment 5 was to measure changes in food and water intake, home-cage
behaviors (posture, grooming, stretching, digging, etc.), and swim-test behaviors
(struggling and floating) in addition to spontaneous motor activity in response to IL-1(3
infused into the LC region. Procedural methods for food and water intake, home-cage
behaviors, and the swim test are detailed in appropriately labeled methods sections
below. See Appendix B for a complete list of home-cage behaviors.
Procedurally, three sets of animals were used in this experiment. The first set of
animals received 0.4 ng IL-1(3/rat or CSF, and spontaneous motor activity, food and
water intake, home-cage behaviors, and activity in a swim test (struggling and floating)
were measured. When the first set of animals did not show any effects of 0.4 ng/rat of
IL-ip either on spontaneous activity or other behaviors, the experiment was repeated
except that a higher dose of IL-lp was given. This second set of animals was infused
with 1.6 ng IL-ip/rat or CSF, and spontaneous motor activity, food and water intake, and
home-cage behaviors were measured. The final set of animals was infused with 1.6 ng
IL-ip/rat or CSF, and activity in a swim test (struggling and floating) was measured.
The first set of animals was infused into the LC region with the smallest dose of
IL-1P that effectively decreased spontaneous motor activity in Exp. 3. Animals were
infused into the LC region with CSF or 0.4 ng/rat of IL-1p, and motor activity, food and
water intake, and home-cage behaviors were measured.

One week later, the same
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animals were reinfused and swim tested. IL-ip infused into the LC region should not
affect behavior for more than 10-12 hrs; therefore, one week between the first infusion
(used to test motor activity, food and water intake and home-cage behaviors) and the
second infusion (used for the swim test) seemed to be an appropriate waiting period. At
the time of the second infusion, a partial counterbalancing procedure was used, based on
the drug previously infused, to assign animals to two matched groups: CSF group or IL1P group. The second set of animals was infused with CSF or 1.6 ng/rat of IL-ip and
motor activity, food and water intake, and home-cage behaviors were measured. The
final set of animals was infused with CSF or 1.6 ng/rat of IL-ip, and swim-test behaviors
were measured. Detailed information is provided below.
Methods
Animals
Animals for 0.4 ng IL-lp/rat and its respective CSF group
Naive male rats were selected from our group-housed colony (lights on from
0700-1900 hrs.) and were transferred into an inverse light: dark period (lights on 24001200 hrs.). After remaining group-housed for three to four weeks, animals were single
housed in a room maintained on an inverse light: dark period that was dedicated to
monitoring of motor activity.

Motor activity, food and water intake, home-cage

behaviors and swim-test behaviors were measured.
Animals for 1.6 ng IL-ip/rat and its respective CSF group
Naive male rats were selected from our group-housed colony and treated as the
0.4 ng IL-ip/rat and the CSF group above. For the rats of this set, only motor activity,
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food and water intake, and home-cage behaviors were measured. Another set of naive
male rats was selected from our group-housed colony and was used to measure swim-test
behaviors. The rats used in the swim-test measurements were placed into single housing
but did not undergo a change into an inverse light: dark period; however, swim-test
behaviors were measured during the dark period. The animals remained single housed in
the colony room (lights on from 0700-1900 hrs.) for approximately three days prior to the
surgical procedure.
General Procedures
Detailed procedural methods for food and water intake, home-cage behavior
observation and the swim test are detailed in the labeled sections below. The procedural
methods for spontaneous motor activity are similar as in previous experiments except for
slight modifications that were incorporated into the new computer software and are
detailed in the general methods section. Surgical and infusion procedural methods are
similar to those described in previous experiments and are also detailed in the general
methods section; therefore, procedural methods are briefly discussed. Once animals were
placed into single housing, they remained under these housing conditions for several days
prior to undergoing surgery.

The animals were anesthetized with Halothane and

implanted with a bilateral cannula aimed at the LC (Table 1). Seven to ten days after
surgery, spontaneous motor activity, food and water intake were recorded for three days
and a mean of these three days was calculated for each variable, representing baseline
motor activity, food and water intake for the animals. On each of these three days, the
animals also were handled. Based on their motor activity, food and water intake, the first
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and second set of animals were assigned to matched groups. The first set of animals was
assigned to two matched groups (n=3 per group), infused with CSF or IL-1[3 (0.4 ng/rat)
and spontaneous motor activity, food and water, home-cage behaviors and activity in a
swim test were measured. The second set of animals was assigned to two matched
groups (n=3 per group), infused with CSF or IL-1p (1.6 ng/rat) and only motor activity,
food and water intake and home-cage behaviors were measured. The third set of animals
was randomly assigned to two groups (n=3-4 per group), infused with CSF or IL-ip (1.6
ng/rat) and activity in a swim test was measured. For all animals, CSF or IL-ip were
infused in an alternating order. Infusions began one hour prior to lights out. After the
infusion, the animals were returned to their home cage. Home-cage behaviors were
observed for a total of two hours during the dark period. Motor activity was recorded for
12 hrs. post-infusion during the dark period. Food and water intake were recorded during
the following light period. Finally, activity in the swim test (struggling and floating) was
measured.
Food and Water Intake
Food and water were provided ad libitum and were measured daily, to the nearest
0.01 g and 1 g respectively, for a three-day period. These three days were averaged and a
mean intake baseline was calculated.

Food and water intake also were recorded

approximately 20 hours post-infusion.
Home-Cage Behaviors
Home-cage behaviors are detailed in Appendix B. Home-cage behaviors were
observed for a total of two hours from hour four to hour six post-infusion. The room was
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illuminated by red light and the duration of each behavior was recorded using a strip
recorder. An investigator sat in the center of the room and timed active and nonactive
behaviors for 4 min. per animal. The order in which the animals were observed followed
the same order in which they were infused (alternating between CSF and IL-1 p).
A strip recorder loaded with block graph paper and advancing at 6 cm/min. was
used to record the appropriate behavior for each animal observed. Specifically, as the
graph paper advanced, a line was drawn and labeled every time a new behavior would
occur. Some of the behaviors that were recorded were as follows: Awake or asleep state,
curled, sitting, digging, eating, grooming, motor behavior, standing, rearing, and
stretching. The lines indicate the beginning and end of a particular behavior and the
distance between the lines were translated into time spent expressing that behavior.
Each animal was observed for 4 min. until all six animals had been observed.
This procedure was repeated three more times, in the same order (totaling four times per
animal), until all animals had been observed for a total of 16 min. each. One minute was
allotted between animals for proper animal identification and to reset the timer (allotting
5 min. per animal/session for a total of 4 sessions). The above procedure allowed the
investigator to observe home-cage behaviors for four-4 min. sampling periods, totaling a
two hour block, during hours four to six post-infusion.
Swim-Test Procedure
Animals that were swim tested in the “0.4 ng IL-ip/rat and CSF set” had been
infused one week earlier and motor activity, food and water intake and home-cage
behaviors had been measured. Animals that were swim tested in the “1.6 ng IL-lp/rat
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and CSF set” were naive. Procedural methods for the swim test for both sets of animals
were the same and are detailed below.
The swim-test procedure used in our laboratory is a modification of a swim test
initially described by (Porsolt et al., 1977). Swim testing was conducted in a Plexiglas
cylinder 65 cm tall, 30 cm in diameter, filled with 50 cm of water (-25° C) in a room
illuminated with a red light. Swim testing occurred four hours post-infusion (post-lights
off). Animals were infused and to prevent the animals from sinking or drowning “water
wings” were attached.

The “water wings” consist of two bubbles side by side,

constructed from large “shipping-bubble-wrap” and are attached to the animal with a strip
of % inch adhesive tape from the midscapular area to the sternum. The animal was
dropped into the swim-tank from ~20 cm above the water level.
The duration of struggling and floating, the two types of swim-test behaviors,
were recorded for a total of 900 seconds (15 min.).

Struggling is defined as the

movement of all paws with the forepaws breaking the surface of the water. Floating is
defined as a semi-motionless state with no voluntary movement of the head or limbs
except when the rat “pushes off’ the side of the tank to prevent from hitting the sides.
After the completion of the swim test, the animal was removed from the swim-tank,
dried, and returned to its home cage.
Statistical Analyses
Spontaneous Motor Activity
All analyses of motor activity were carried out on each set of animals separately.
Baseline motor activity for the 0.4 ng IL-1 (3/rat and the 1.6 ng of IL-ip/rat and their
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respective CSF groups was analyzed by a RM-ANOVA factorial design (12 [hour] X 2
[drug level]). Post-infusion motor activity for the 0.4 ng IL-1 p/rat and the 1.6 ng of IL1p/rat and their respective CSF groups was analyzed by a RM-ANOVA factorial design
(12 [hour] X 2 [drug level]). Each hour of post-infusion motor activity for the 0.4 ng IL1p/rat and the 1.6 ng of IL-1p/rat and their respective CSF groups was analyzed by a
separate one-way ANOVA (1X 2 [drug level]).
Food and Water Intake. Home-Cage Behaviors, and Swim-Test Behaviors
All analyses of these measures were carried out by a 2 X 2 ANOVA (drug [IL-ip
(0.4 or 1.6 ng /rat] vs. CSF [CSF for the 0.4ng group and for the 1.6ng group] X set of
animals [the 0.4 ng set or the 1.6 ng set]). These included baseline food and water intake,
post-infusion food and water intake, individual home-cage behaviors, and swim-test
behaviors (struggling and floating). Following the ANOVAs and where appropriate, post
hoc analyses were conducted by a Student-Newman-Keuls test.
Results
Spontaneous Motor Activity
0.4 ng IL-1 p/rat and its respective CSF group
A RM-ANOVA (hour X drug level) analyzing baseline motor of the 0.4 ng IL1p/rat group and its respective CSF group yielded a main effect of hour [F( 11, 44) =
6.661, p < .001] and a statistically significant two-way interaction [F( 11, 44) = 2.08, p =
.042] (Figure 13).

The remaining main effect of drug level was not statistically

significant. However, inspection of the data suggested that activity in hour 12, which is
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Figure 13. Mean (±SEM) ambulatory counts/hour (dark period spontaneous motor
activity) of rats that have not been infused (baseline, top left) and of rats infused (post
infusion) with CSF or IL-ip (0.4 or 1.6 ng/rat) into the LC region (bottom left and right).
The horizontal black bar along the abscissa designates the time period in which the
investigator is in the room scoring the behavior of the animals and pertains only to the
post-infusion data. The asterisk (*) designates a significance level of p < 0.05. * = 1.6
ng IL-ip/rat vs. its respective CSF group.
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not affected by infused IL-1(3, might be responsible for the significant interaction. When
baseline motor activity was analyzed by a RM-ANOVA (hour X drug level) eliminating
hour 12, the analysis yielded a main effect of hour [F(10, 40) = 5.48, p < .001] but the
main effect of drug level and the two-way interaction did not reach statistical
significance.

This analysis indicated that baseline motor activity of the groups was

similar.
A RM-ANOVA (hour X drug level) analyzing post-infusion motor activity
yielded a main effect of hour [F(l 1, 44) = 3.84, p = .001] which was derived from a rise
in motor activity toward the end of the dark period (Figure 13). The remaining main
effect of drug level and the two-way interaction (hour X drug level) were not statistically
significant. In separate one-way ANOVAs (each hour X drug level) of post-infusion
motor activity, no effect of drug level at any hour reached statistical significance.
1.6 ng IL-lB/rat and its respective CSF group
A RM-ANOVA (hour X drug level) analyzing baseline motor of the 1.6 ng ILlp/rat group and its respective CSF group yielded a main effect of hour [F(l 1,44) = 2.96,
P = .005]. The remaining main effect of drug level and the two-way interaction were not
statistically significant.

This analysis indicated that, while baseline motor activity

differed depending on the hour of dark period, there was no difference in baseline motor
activity at any hour between any of the groups prior to treatment.
A RM-ANOVA (hour X drug level) analyzing post-infusion motor activity did
not yield any statistically significant main effects of hour, drug level, or the two-way
interaction. However, the main effect of drug level approached statistical significance
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[E0> 4) - 5.85; 2 - .073] (Figure 13). Separate one-way ANOVAs (each hour X drug
level) of post-infusion motor activity yielded a statistically significant difference at two
hours (Figure 13). Specifically, 1.6 ng of IL-ip/rat produced a decrease in motor activity
at hour three [F(l, 5) = 9.20, p = .039] and hour four [F(l, 5) = 22.05; p - .009] post
infusion.
Food and Water Intake
A 2 X 2 ANOVA (drug [IL-ip (0.4 or 1.6 ng /rat] vs. CSF [CSF for the 0.4ng
group and for the 1.6ng group] X set of animals [the 0.4 ng set or the 1.6 ng set]) of
baseline food and water intake did not yield main effects or interactions that were
statistically significant. These analyses indicate that baseline food and water intake did
not differ across the IL-ip-infused groups and their respective CSF-infused groups. The
2 X 2 ANOVAs of post-infusion food and water did not yield any statistically significant
differences except for a main effect of set of animals in the water intake analysis [F(l,
11) = 5.98, p = .040]. The significant main effect in the water intake analysis indicates
that the amount of water drank by the first set of animals (0.4 ng IL-ip/rat group and its
respective CSF group) was different from (less than) the second set of animals (1.6 ng ILip/rat group and its respective CSF group); see Figure 14.
Home-Cage Behaviors
A 2 X 2 ANOVA (drug [IL-ip (0.4 or 1.6 ng /rat] vs. CSF [CSF for the 0.4ng
group and for the 1.6ng group] X set of animals [the 0.4 ng set or the 1.6 ng set]) of
individual home-cage behaviors did not yield any statistically significant differences
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Figure 14. Mean (±SEM) food and water intake o f rats infused with CSF or 0.4 ng o f IL1p/rat (top left and bottom left) and of rats infused with CSF or 1.6 ng o f IL-1 p/rat (top
right and bottom right) into the LC region.
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except for a main effect of set of animals for the curled (awake) behavior [F(l, 11) =
5.41, p = .048]. This indicates that the time spent expressing the curled (awake) behavior
by the first set of animals (0.4 ng IL-ip/rat group and its respective CSF group) was
different from (more than) the second set of animals (1.6 ng IL-lp/rat group and its
respective CSF group); see Figure 15.
Swim-Test Behaviors
A 2 X 2 ANOVA (drug [IL-1(3 (0.4 or 1.6 ng /rat] vs. CSF [CSF for the 0.4ng
group and for the 1.6ng group] X set of animals [the 0.4 ng set or the 1.6 ng set]) of
struggling behavior yielded a significant main effect of drug [F(l, 12) = 7.78, p = .021]
(Figure 16). This indicates that animals infused with IL-1p struggled more than animals
infused with CSF. The remaining main effect of set of animals and the interaction were
not statistically significant. The 2 X 2 ANOVA (drug [IL-ip (0.4 or 1.6 ng /rat] vs. CSF
[CSF for the 0.4ng group and for the 1.6ng group] X set of animals [the 0.4 ng set or the
1.6 ng set]) of floating behavior did not yield any statistically significant effects (Figure
16). However, inspection of the raw data showed that the above statistics were possibly
affected by one score from an animal in the CSF group (the respective CSF group for the
1.6 ng IL-ip/rat group) that floated for a long period. If that single high score is omitted,
the 2 X 2 ANOVA yields a significant main effect of drug [F(l, 11) 6.53, p = .034]; see
Figure 16. This indicates that animals infused with IL-lp tended to float more than
animals infused with CSF.
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Discussion
Spontaneous Motor Activity
Measurement of baseline motor activity for the pre-0.4 ng IL-ip/rat and its
respective pre-CSF group revealed that the two groups began the experiment with similar
motor activity when hour 12 is omitted from the data. Measurement of baseline motor
activity for the pre-1.6 ng IL-ip/rat and its respective pre-CSF group revealed that these
two groups began the experiment with comparable spontaneous motor activity.
RM-ANOVAs (hour X drug level) of post-infusion motor activity for the 0.4 ng
IL-ip/rat and the 1.6 ng IL-ip/rat and their respective CSF groups both yielded a main
effect of hour. Flowever, the main effect of hour is not of particular interest; what is of
interest is the main effect of drug level or the two-way interaction. In the analysis of the
1.6 ng IL-lp/rat and its respective CSF group, the effect of drug level approached
significance (p = .073). Moreover, separate one-way ANOVAs (each hour X drug level)
indicate that 1.6 ng IL-ip/rat significantly decreased spontaneous motor activity at hours
three and four post-infusion. It can be noted that these differences were seen despite the
fact that the presence of the investigator in the activity room (in order to record homecage behaviors) apparently decreased activity of the CSF-infused group in the hours
when the investigator was present. Such results indicate that 1.6 ng of IL-ip/rat was
sufficient to decrease motor activity. However, similar analyses of the effects seen from
an infusion of 0.4 ng IL-ip/rat yielded neither a significant main effect of drug level nor
a significant two-way interaction. Also, separate one-way ANOVAs (each hour X drug
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level) indicated that 0.4 ng IL-ip/rat did not decrease spontaneous motor activity at any
hour.
It is unclear as to why 0.4 ng IL-ip/rat infused into the LC region did not produce
a significant decrease in spontaneous motor activity as seen in Exp. 3. Perhaps the small
number of animals in this experiment is the reason for the lack of significance. However,
it is noteworthy that home-cage behaviors of the 0.4 ng IL-ip/rat and its respective CSF
group also did not differ (Figure 15).
Food and Water Intake
Measurement of baseline food and water intake for the groups that received IL-ip
(0.4 ng IL-ip/rat and the 1.6 ng IL-ip/rat) and for their two respective CSF groups
revealed that the groups began the experiment with comparable intake prior to drug
administration. The analyses of post-infusion food and water intake indicate that an
infusion of IL-ip did not decrease food or water intake (Figure 14). However, it is
possible that both doses of IL-lp (0.4 and 1.6 ng/rat) decreased food and water intake but
because of the method in which these variables were measured the decreases were not
detected. If IL-ip decreases food and water intake during the early portion of the dark
period, and rats eat and drink throughout their active period, then they could have
compensated by eating slightly more during the remaining part of the dark period. If this
were true, the decrease in food and water intake would not have been detected 12+ hours
after an infusion of IL-1p into the LC region.
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Home-Cage Behaviors
Analysis of post-infusion nonactive and active home-cage behaviors indicated
that IL-ip did not affect any home-cage behavior differently from CSF (Figure 15).
Although statistical analyses indicate that the first set of animals (0.4 ng IL-ip/rat group
and its respective CSF group) was different from (i.e. spent more time in the curled
[awake] position) the second set of animals (1.6 ng IL-ip/rat group and its respective
CSF group), it is perhaps noteworthy that within each set of animals there were
differences (not statically significant) between the IL-ip-infused groups and their
respective CSF-infused groups. Specifically for nonactive behavior, the 0.4 ng IL-ip/rat
group spent approximately four times less in the curled (awake) position than its
respective CSF group.

For active behaviors, the 0.4 ng IL-ip/rat group spent

approximately four times longer grooming than its respective CSF group, but the 1.6 ng
IL-ip/rat group only spent a mean of 2.0 seconds rearing while its respective CSF group
spent a mean of 151.67 seconds rearing.
behaviors as well as active behaviors.

IL-ip-infused rats expressed nonactive

This suggests that IL-1P does not decrease

spontaneous motor activity by immobilizing the rats or by causing lethargic behavior.
Swim-Test Behaviors
Analysis of post-infusion swim-test behavior indicate that animals infused with
IL-ip struggled more and floated more than animals infused with CSF. An analysis of
post-infusion struggling behavior yielded a main effect of drug. This indicates that ILlp-infused animals struggled more than did CSF-infused animals.

With respect to
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floating behavior, the 2 X 2 ANOVA that included all of the animals did not yield
statistically significant effects. However, the variance was evidently affected by a single
high score of a CSF-infused animal. The 2 X 2 ANOVA omitting this high scoring
animal yielded a significant main effect of drug. Collectively, the results from the swim
test indicate that IL-lp increased both struggling and floating behavior.

Although

previous experiments have shown that IL-ip infused into the LC region decreases
spontaneous motor activity, the fact that struggling behavior in the swim test was
increased in IL-lp-infused animals suggests that the effect of IL-ip should not be
characterized simply as an immobilization of the animal.
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CHAPTER EIGHT
Experiment 6: Central IL-lra and Intraperitoneal LPS
Rationale
Intraperitoneally injected LPS causes the induction of IL-1 in brain microglia. If
the production of IL-1 in the brain mediates the decrease in spontaneous motor activity
after ip LPS, then interleukin-1 receptor antagonist (IL-lra) given centrally should block
the effects of ip LPS. IL-lra is a protein that is a specific antagonist for IL-1 Type I
receptors. Moreover, if increased activity of LC neurons produced by IL-1 causes a
decrease in motor activity after ip. LPS, then IL-lra infused into the LC region, and not
into LC surrounding regions, should prevent the decrease in motor activity after ip LPS.
Experiment 6 tested whether IL-lra infused into the LC region would block the decrease
in spontaneous motor activity in response to an injection of ip LPS.
Methods
Surgical. General. Spontaneous Motor Activity, and Infusion Procedures
The procedural methods are similar to all of the previous experiments. Briefly,
male rats were obtained from our group housed colony and single housed in a room
where spontaneous motor activity was monitored by a computer-controlled system. After
several days of housing under these conditions, animals underwent surgery. The animals
were anesthetized with Halothane and implanted with cannulae aimed at the LC (n=20),
lateral to the LC (1-LC), medial to the LC (m-LC), the cerebral aqueduct (AQ), the fourth
ventricle (4V), and the area postrema/nucleus of the solitary tract (AP/NST); See Table 1.
The latter five groups contained 6-7 animals per group. Seven to ten days after surgery,
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spontaneous motor activity was recorded for three days and a mean of these three days
was calculated, representing baseline motor activity for the animals. On each of these
three days, the animals also were handled. Based on their baseline motor activity, the
animals with a cannula aimed at the LC region were assigned to three groups. One LC
group was infused with CSF and injected with ip LPS (LC-CSF + ip LPS) and another
LC group was infused with IL-lra and injected with ip phosphate buffered saline vehicle
(LC-IL-lra + ip VEH).

Drug administration for the remaining LC groups will be

explained below. The LC-CSF + ip LPS group was predicted to be a positive control
condition since CSF infused into the LC region should have no effect and therefore motor
activity should be decreased by the ip LPS.

The LC-IL-lra + ip VEH group was

predicted to be a negative control condition since IL-lra infused into the LC was also
expected to have no effect and therefore motor activity should not be affected by ip VEH.
The remaining LC group as well as all of the other groups whose animals had cannula
aimed at other brain regions (AQ, 1-LC, m-LC, 4V, and the AP/NST) were infused with
IL-lra and injected with ip LPS. The animals were infused with CSF or IL-lra (40
pg/rat) in a total volume of 2 pl/rat, and the central infusion was immediately followed
by an ip injection of VEH or LPS (lOpg/kg of body weight). Infusions/injections began
1 hour prior to lights out (lights out - 19:00 hrs.). After the infusion/injection, the
animals were returned to their home cage and motor activity was recorded for 12 hrs.
post-infusion/injection during the dark period.
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Statistical Analyses
Baseline motor activity for all groups was analyzed by a RM-ANOVA factorial
design (12 [hour] X 8 [groups; i.e., LC-CSF + ip LPS, LC-IL-lra + ip VEH, LC, 1-LC,
m-LC, AQ, 4V, and AP/NST]). Post-infusion motor activity of the positive and negative
control conditions (LC-CSF + ip LPS group and the LC-IL-lra + ip VEH group) was
analyzed by a RM-ANOVA (12 [hour] X 2 [conditions]). Post-infusion motor activity of
all groups was analyzed by a RM-ANOVA (12 [hour] X 8 [groups]). Finally, each hour
of post-infusion motor activity was analyzed by a separate one-way ANOVA ( 1 X 8
[groups]). Following each of the separate one-way ANOVAs at each hour and where
appropriate, post hoc analyses were conducted by a Dunnett’s test comparing the positive
control condition (LC-CSF + ip LPS) with each of the other seven groups.
Results
A RM-ANOVA (12 [hour] X 8 [groups]) analyzing baseline motor activity
yielded a significant main effect of hour (F(ll, 550) = 22.09, p < .001]. The remaining
main effect of group and the two-way interaction were not statistically significant. This
analysis indicated that, while baseline motor activity differed depending on the hour of
the dark period, there was no difference in baseline motor activity at any hour between
any of the groups prior to treatment.
A RM-ANOVA (12 [hour] X 2 [conditions]) analyzing post infusion motor
activity of the positive and negative conditions (LC-CSF + ip LPS group and the LC-ILlra + ip VEH group, respectively) yielded a significant main effect of hour (F(l 1, 121) =
5.98, p < .001] which was derived from a “U” pattern of motor activity seen during the
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dark period of post-infusion/injection (Figure 17, top left). The remaining main effect of
condition did not reach statistical significance.

However, the two-way interaction

approached statistical significance [F(ll, 121) = 1.79, p = .063]. Inspection of the data
showed that large amounts of variability occurred during hours 1,2, 11, and 12, and these
hours generally are not affected by ip LPS. Therefore, post-infusion motor activity of the
positive and negative conditions were reanalyzed by a RM-ANOVA (8 [hour] X 2
[conditions]) that eliminated hours 1, 2, 11, and 12. The reanalysis no longer yielded a
significant main effect of hour, but did yield a main effect of condition (F(l, 11) = 5.65, p
= .037]. This main effect of condition was derived from the decrease in spontaneous
motor activity seen in the LC-CSF + ip LPS group when compared to the LC-IL-lra + ip
VEH group. The two-way interaction was not statistically significant.
A RM-ANOVA (12 [hour] X 8 [group]) analyzing post-infusion motor activity
yielded a main effect of hour [F(ll, 550) = 36.64, p < .001] and was derived from a
“wide-U” pattern of motor activity seen during the dark period of post-infusion/injection
(Figure 17, bottom graphs). The remaining main effect of group did not reach statistical
significance. However, the two-way interaction approached statistical significance [F(77,
550) = 1.30, p = .053]. A significant two-way interaction indicates that groups included
in this experiment, in response to the treatments administered, showed different effects on
motor activity across hours of the dark period.
Since the interaction term in the previous analysis approached statistical
significance, and it was important to thoroughly examine whether IL-lra was able to
block the effects of ip LPS (especially in the LC region) differentially when infused into
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Spontaneous Motor Activity (Ambulatory Counts/Hour)

Central IL-lra and Intraperitoneal LPS

300
200
100

0

1 2 3 4 5 6 7 8 9 10 11 12
Hours Post-Infusion/Injection

Hours Post-Infusion/Injection

Figure 17. Mean (±SEM) ambulatory counts/hour (dark period spontaneous motor
activity) of rats centrally infused with CSF or IL-lra (40 pg/rat) into the LC or LC
surrounding regions. Central infusions were immediately followed by an ip injection of
VEH or LPS (10 pg/kg).
The asterisk (*) designates a significance level of p < 0.05 and signifies that the LC-ILlra + ip VEH group is different from the LC-CSF + ip LPS group. Note that the LC-CSF
+ ip LPS group is included in all of the graphs for easier inspection of the data.
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other brain regions, another RM-ANOVA (12 [hour] X 6 [group]) of post-infusion motor
activity was conducted using only the data from the six groups that were infused with ILlra and injected with ip LPS. This RM-ANOVA yielded a main effect of hour [F( 11,
429) = 31.90, p < .001], which was derived from a “wide-U” pattern of motor activity
seen during the dark period of post-infusion/injection. Furthermore, the remaining main
effect of group and the two-way interaction both approached statistical significance [F( 1,
39) = 2.38, p = .056] and [F(55, 429) = 1.28, p = .095], respectively.

However,

inspection of the data showed that large amounts of variability occurred during hours 1,
2, 11, and 12, and these hours generally are not affected by ip LPS. Hours one and two
are too early post-injection for the effects of 10 pg/kg of ip LPS, and by hours 11 and 12
post-injection the animals have already recovered from the effects of ip LPS. Therefore,
post-infusion motor activity of the six groups that were infused with IL-lra and injected
with ip LPS were reanalyzed by a RM-ANOVA (8 [hour] X 6 [group]) that eliminated
hour 1,2, 11 and 12. The reanalysis by an RM-ANOVA (8 X 6) yielded a main effect of
hour [F(7, 273) = 12.87, p < .001]. The remaining main effect of group and the two-way
interaction were not statistically significant. Collectively, the (12 [hour] X 6 [group]) and
(8 [hour] X 6 [group]) RM-ANOVAs indicate that the p values found in the (12 [hour] X
6 [group]) RM-ANOVA are due to hours 1, 2, 11 and 12. These results indicate that
animals infused with IL-lra into LC and LC surrounding regions and then injected with
ip LPS showed similar decreases in motor activity across the hours that are generally
affected by 10 pg/kg of ip LPS (hours 3-10).
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Finally, analyzing post-infusion/injection motor activity by separate one-way
ANOVAs (each hour X 8 [groups]) of all eight groups yielded a significant difference at
hour five [F(7, 57) = 2.81, p = .015] (Figure 17). Dunnett’s tests performed at hour five
comparing the positive control condition (LC-CSF + ip LPS) with the seven remaining
groups yielded a single statistically significant difference that was derived from a non
decrease in motor activity of the negative control group (LC-IL-lra + ip VEH); see
Figure 17.
Discussion
Measurement of baseline spontaneous motor activity revealed that the eight
groups began the experiment with comparable motor activity. When baseline motor
activity was analyzed by a RM-ANOVA (hour X group) the significant main effect of
hour can be described by a rise in motor activity toward the end of the dark period.
However, the main effect of group and the two-way interaction were not statistically
significant.
The prediction that the LC-CSF + ip LPS and the LC-IL-lra + ip VEH were
positive and negative control conditions was confirmed by the findings. For the positive
control condition, CSF infused into the LC region should have no effect and therefore
motor activity should be decreased by the ip LPS. Figure 17 (top left) shows that ip LPS
effectively decreased spontaneous motor activity for approximately four hours post
injection. These results are similar to the decreases in motor activity in response to ip
LPS seen in Exp. 1. For the negative control condition, IL-lra infused into the LC was
also expected to have no effect and therefore motor activity should not be decreased by ip
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VEH. Figure 17 (top left) shows that ip VEH did not decrease spontaneous motor
activity, as seen in the LC-CSF + ip LPS. Comparison of the LC-CSF + ip LPS group
with the LC-IL-lra + ip VEH group showed statistically significant differences in
spontaneous motor activity in the analysis of hours 3-10, which is when ip LPS affects
spontaneous motor activity.
Post-infusion/injection motor activity analyzed by a RM-ANOVA (12 [hour] X 8
[group]) yielded a two-way interaction that approached statistical significance (p = .053).
A two-way interaction in this experiment indicates that the groups, in response to the
treatments administered, showed different effects on motor activity across hours of the
dark period. Specifically, the two-way interaction could refer to motor activity of the
LC-CSF + ip LPS and the LC-IL-lra + ip VEH groups differing from one another across
hours of the dark period. It could also refer to motor activity of these two conditions
differing from the remaining groups that received central IL-lra + ip LPS across hours of
the dark period. Finally, it could also refer to one of the groups that received central ILlra + ip LPS differing from another group that also received central IL-lra + ip LPS. An
inspection of Figure 17 shows that the LC-IL-lra + ip VEH group did not show a
decrease in spontaneous motor activity as did the remaining seven groups. Therefore, it
appears that the two-way interaction term refers to the LC-IL-lra + ip VEH group
differing from all other groups.
Since post-infusion/injection motor activity analyzed by a RM-ANOVA (12
[hour] X 8 [group]) yielded a two-way interaction that approached statistical significance
(E = -053), and the two-way interaction term refers to several possible interactions
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between the groups, it was important to determine if the interaction term referred to a
significant difference between any of the six groups that were infused with IL-lra and
injected with ip LPS. All of the groups can be seen in Figure 17. As suggested by visual
comparison of these groups, statistical analyses indicate that all six groups showed
similar decreases in spontaneous motor activity during the middle portion of the dark
period (hours 3-10).
IL-lra infused into the LC region and LC surrounding regions did not block or
attenuate the expected decrease in spontaneous motor activity in response to ip LPS.
Although central IL-lra was expected to block the decrease in motor activity that was
anticipated to occur in the LC-CSF + ip LPS group, all of the groups that received ip LPS
(including those that were infused with IL-lra) showed a similar decrease in spontaneous
motor activity. IL-lra was unable to attenuate the decrease in spontaneous motor activity
seen after an injection of ip LPS. IL-lra also was unable to delay the onset of ip LPS
decreases in spontaneous motor activity and unable to shorten the time to recover from a
decrease in motor activity produced by ip LPS. These results indicate that the dose of ILlra (40 pg/rat) administered in this experiment was unable to block or affect the decrease
in spontaneous motor activity seen after an injection of ip LPS (10 pg/kg).
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CHAPTER NINE
Conclusions
Collectively, the experiments conducted tested whether the decrease in
spontaneous motor activity that occurs after an injection of ip LPS is mediated by the
induction of IL- 1 in the LC region. Exp. 1 tested whether a range of ip LPS doses would
cause dose-dependent decreases in spontaneous motor activity. Exp. 2, 3 and 4 tested
whether LPS or IL-1[3 infused into the LC region or LC surrounding regions would cause
a similar decrease in spontaneous motor activity as seen after ip LPS. Exp. 5 measured,
in addition to changes in spontaneous motor activity, changes in food and water intake,
home-cage behaviors, and swim-test behaviors in response to an infusion of IL-1(3 into
the LC region. Finally, Exp. 6 tested whether IL-lra infused into the LC region would
block the decrease in spontaneous motor activity in response to an injection of ip LPS.
The primary purpose of Exp. 1 was to test whether a range of ip LPS doses would
cause dose-dependent decreases in spontaneous motor activity. The highest doses of LPS
used tended to decrease spontaneous motor activity somewhat more than the lowest dose
of LPS. A secondary purpose of Exp. 1 was to test whether handling the animals, a
procedure that was needed for all of the infusion experiments (Exps. 2-6), would
significantly alter the overall effects in response to ip LPS. Results showed that ip LPS
produced a similar decrease in spontaneous motor activity regardless of whether animals
were handled or nonhandled.
The primary purpose of Exp. 2 was to test whether LPS infused into the LC
region would cause a decrease in spontaneous motor activity that is similar to the
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decrease seen after ip LPS.

Indeed, LPS infused into the LC region decreased

spontaneous motor activity in a time- and dose-dependent manner. The onset of effect
for all the doses of infused LPS that significantly decreased spontaneous motor activity
occurred three hours post-infusion. It is interesting that regardless of the dose of LPS,
when an effect was seen, it first appeared three hours post-infusion. This three-hour
delay in the onset of the decrease in motor activity may be explained by the time required
for LPS to cause the induction of IL-1 in the brain. But while effective doses showed
initial effects three hours post-infusion, the highest doses of LPS then suppressed
spontaneous motor activity more than did the lowest dose of LPS when activity decreases
appeared. Moreover, the time to recover from the effects of LPS was more delayed in the
groups that received the highest doses of LPS than in the group that received the lowest
doses, suggesting that the highest doses of LPS maintain the induction of IL-1 for longer
periods than the lowest doses of LPS.
The primary purpose of Exp. 3 was to test whether IL-1 directly infused into the
LC region would cause a decrease in spontaneous motor activity that is similar to the
decrease seen after ip LPS (Exp. 1) or an infusion of LPS into the LC region (Exp. 2),
thereby further suggesting that ip LPS or LPS infused into the LC region acts by
stimulating IL-1 in the LC region. Indeed, a dose-dependent decrease in spontaneous
motor activity was seen when IL-1 (3 was infused into the LC region, and the decrease was
similar to what was seen after ip LPS or after an infusion of LPS into the LC region.
Similarities of the effects produced by ip LPS, LPS into the LC region, or IL-ip into the
LC region were as follows: 1) all three treatments produced a decrease in motor activity
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that was roughly similar in magnitude and pattern, 2) the onset of the decrease in motor
activity occurred three hours after a drug was administered, and 3) by the end of the dark
period, all treatments groups had recovered from the decrease in spontaneous motor
activity.
Questions arise from the observation that the onset of the decrease in motor
activity occurred at the same time in animals that received ip LPS, LPS into the LC
region, or IL-ip into the LC region. Previous findings have shown that LPS causes the
induction of IL-1 in the brain (Quan et al., 1994; Weiss et al., 1994). If ip LPS (Exp. 1)
or infusions of LPS into the LC region (Exp. 2) produce a decrease in motor activity via
induction of IL-1 in the brain to stimulate LC neurons, then an infusion of IL-1 p directly
into the LC region should decrease spontaneous motor activity sooner than LPS
(peripheral or central). Whereas LPS must first cause the induction of IL-1 to bring about
the decrease in spontaneous motor activity, IL-1 directly infused into the LC region
should eliminate the need for induction of IL-1 and consequently the effects on
spontaneous motor activity would be expected to occur sooner than when LPS is given.
The observation that the onset of the decrease in motor activity occurred at the same time
in animals that received ip LPS, LPS into the LC region, or IL-ip into the LC region
suggests that both LPS and IL-1 cause the induction of some other transmitter/substance
in the brain that brings about the decrease in spontaneous motor activity.
Another important point can be made regarding the similarity of spontaneous
motor activity of the animals injected with ip LPS and animals infused with IL-ip into
the LC region. Although as pointed out above findings from Exp. 1 and 3 reveal that rats
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injected with 10 jug/kg of ip LPS showed similar decreases in spontaneous motor activity
as did the rats infused with IL-1(3 into the LC region, a pilot study suggests that these two
groups of rats are affected differently by these treatments. Animals injected with ip LPS
were observed to be sedated and lethargic (pilot study) whereas such sedation was not
evident when IL-ip was infused into the LC region (Exp. 5). Thus, the post-treatment
behavior of these two groups of animals differs considerably despite the fact that the
decrease in spontaneous motor activity recorded by the computer-controlled system was
similar in both groups.
The purpose of Exp. 4 was to test whether the decrease in spontaneous motor
activity seen after an infusion of IL-1(3 into the LC region was specific to the LC. This
was done by assessing whether the decrease in motor activity would occur only if IL-1P
were infused into the LC region and would not occur if IL-1(3 were infused into regions
surrounding the LC. Unexpectedly, motor activity was similarly affected when IL-ip
was infused into all brain regions including the LC region with all groups showing a
moderate decrease in motor activity at hours 2-5 post-infusion. To assess whether motor
activity was indeed decreased by an infusion of IL-ip, a RM-ANOVA was conducted
with an added control group that showed normal activity (i.e., no decrease). The analysis
indicated that an infusion of IL-lp did not produce a statistically significant decrease in
spontaneous motor activity. Based on the results that had been obtained in the third
experiment, 0.4 ng of IL-ip/rat had been chosen for use in Exp. 4 because this was found
to be the lowest dose of IL-1P that caused a statistically significant decrease in motor
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activity. It is not evident why 0.4 ng of IL-ip/rat did not yield statistically significant
decreases in motor activity in Exp. 4, at least when infused into the LC region. Although
in Exp. 4 the pattern of motor activity was similar when IL-ip was infused into all brain
regions, comparison to a control group revealed that IL-ip did not significantly decrease
motor activity when infused into any brain region including the LC. It was expected that
an infusion of IL-lp into the LC region would decrease motor activity, and since this did
not occur, the results from Exp. 4 were inconclusive.
The purpose of Exp. 5 was to measure changes in food and water intake, homecage behaviors, and swim-test behaviors in addition to spontaneous motor activity in
response to IL-ip infused into the LC region. Collectively, the results from Exp. 5
indicate that while such infusion decreases spontaneous motor activity, the effects from
IL-ip infused into the LC region cannot be characterized as immobilizing the animal.
This conclusion is supported by the observation that many normal home-cage behaviors
of the IL-ip-infused animals and CSF-infused animals did not differ. Furthermore, the
fact that in the swim test animals infused with IL-ip struggled more than animals infused
with CSF indicates that animals infused with IL-ip can be more active than animals
infused with CSF, and that animals are not immobilized or sedated by an infusion of IL1P into the LC region.
It is interesting that although infusions of IL-ip decreased spontaneous motor
activity, such infusion increased struggling behavior in the swim test. The different
effects caused by IL-ip raise the possibility that spontaneous motor activity and
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struggling in the swim test are different types of active behaviors.

Specifically,

spontaneous motor activity is measured in the home cage of an animal that undergoes
little or no stress during the measurement procedure; in contrast, the swim test requires
the animal to swim in a tank of cool water for 15 minutes (moderate stress). The
difference in stress level between these two procedures could be responsible for the
different effects of IL-ip on activity (spontaneous motor activity or activity in the swim
test).
The purpose of Exp. 6 was to test whether IL-lra infused into the LC region
would block the decrease in spontaneous motor activity in response to an injection of ip
LPS. IL-lra was unable to attenuate the decrease in spontaneous motor activity seen
after an injection of ip LPS. This experiment showed that IL-lra also was unable to
delay the onset of the decrease in spontaneous motor activity produced by ip LPS and
was unable to shorten the time to recover from the decrease in motor activity caused by ip
LPS. At least for the dose of IL-lra (40 pg/rat) administered in this experiment, the
results indicate that IL-lra was unable to block or affect the decrease in spontaneous
motor activity seen after an injection of ip LPS (10 pg/kg).
In summary, the findings do not support the hypothesis that the decrease in
spontaneous motor activity that occurs after an injection of ip LPS is mediated by the
induction of IL-1 in the LC region. First, IL-lra was unable to block the decrease in
spontaneous motor activity seen after an injection of ip LPS. Other findings suggest why
it was that IL-lra was unable to block the effects of ip LPS. The pilot study alluded to
earlier indicated that although rats injected with 10 pg/kg of ip LPS showed a decrease in

95

spontaneous motor activity that was similar to what was seen in rats infused with IL-1P
into the LC region (Exp. 3 and 5), the rats given ip LPS were observed to be sedated and
lethargic. In contrast, the animals infused with IL-1p into the LC region (Exp. 5) were
not sedated and lethargic. Thus, the post-treatment behavior of these two groups of
animals differs considerably despite the fact that the decrease in spontaneous motor
activity recorded by the computer-controlled system was similar in both groups. It seems
likely that the decrease in spontaneous motor activity produced by ip LPS is but one
aspect of a number of behavioral changes that are likely to depend on activation of many
brain regions including the LC region by ip LPS, suggesting that the effects of ip LPS are
more generalized than the effects of IL-1 p infused into the LC region. If the effects of ip
LPS are more generalized, then it is not surprising that the effects of ip LPS could not be
blocked by an infusion of IL-1 ra into a single brain region.
Second, it was expected that if ip LPS (Exp. 1) or infusions of LPS into the LC
region (Exp. 2) produce a decrease in motor activity via the induction of IL-1 in the brain
to stimulate LC neurons, then an infusion of IL-1 p directly into the LC region should
cause the onset of the decrease in spontaneous motor activity to occur sooner than when
LPS (peripheral or central) is given. However, results showed that the onset of the
decrease in motor activity for all three treatment groups occurred three hours after drug
administration. That the delay of onset of effect was similar for all three treatment
groups

is

consistent

with

the

possibility

that

induction

of

some

other

transmitter/substance in the brain, which IL-1 and LPS both induce, is what brings about
the decrease in spontaneous motor activity. If the effects of ip LPS are mediated by some
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other substance in the brain that is not IL-1, then an infusion of IL-lra into the brain (any
region) would not be expected to block the decrease in motor activity seen after ip LPS.
In conclusion, we hypothesized that the decrease in spontaneous motor activity
that occurs after an injection of ip LPS is mediated by the induction of IL-1 in the LC
region. Collectively, the findings do not support the above hypothesis.
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NOTES
'Coronal view of the structures that were targeted with cannulae.
2

Coronal view of cannulae that were implanted and aimed at the LC region.
Coronal view of cannulae that were dorsal to the cannulae aimed at m-LC.

4Coronal view of cannulae that were implanted and aimed at the LC region.

Permission to print and modify all of the above mentioned figures was obtained
from Academic Press, also see Appendix C. The Rat Brain in Stereotaxic Coordinates,
by G. Paxinos and C. Watson, 1997, New York: Academic Press. Copyright © 1997 by
Academic Press. Adapted with permission by Academic Press.

107

APPENDICES
Appendix A: Cannula and Infusion Needle Construction
Each cannula was constructed from 26 gauge (GA) intradermal bevel needles
(Becton Dickinson), 3/8 in. in length with the plastic hub melted off (Fig. 18.1). The
distal end of the needle was attached to a narrow silicone tubing [0.012 inches (in.) inter
diameter (I.D.) X 0.025 in. outer-diameter (O.D.) from Technical Products, Inc.]. The
length of the narrow silicone tubing is 5 cm (Fig. 18.2). Also attached to the distal end of
the needle and surrounding the narrow tubing, was a larger silicone tubing (0.040 in. I.D.
X 0.085 in. O.D. from Technical Products, Inc.). The length of the larger silicone tubing
is exactly 3.2 cm (Fig. 18.3). The total length of the cannula from the tip of the needle to
the end of the large tubing was exactly 4.2 cm (Fig. 18.4) and to the end of the narrow
tubing it is 6 cm (Fig. 18.5), so that the narrow tubing extends 1.8 cm from the end of the
large tubing. To prevent clogging of the cannula after it has been implanted, an obturator
(a thin piece of nylon wire) (Fig. 18.6) that is the entire length of the cannula (6 cm), is
inserted into the narrow tubing and glued/sealed with silicone glue.
At the time of infusion, a stainless steel infusion needle attached to a microsyringe
was inserted into the narrow silicone tubing of the implanted cannula. The infusion
needle (no bevel) was constructed from 30 GA stainless steel tubing that is 4 cm in length
(Fig. 18.7) surrounded by 23 GA stainless steel tubing that is 1.5 cm long (Fig. 18.8).
One end of the 23 GA tubing is rounded (Fig. 18.9) and the remaining end was soldered
to the 30 GA tubing (Fig. X-10). The 2 pieces of tubing, 23 GA and 30 GA, were
positioned so that one end of the 30 GA tubing (the infusion needle tip) protruded exactly
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1.5 cm from the rounded end of the 23 GA tubing (Fig. 18.11). The distal end of the
infusion needle tip was attached to a ~75 cm polyethylene (PE 10) tubing (Fig. 18.12).
The remaining end of the PE 10 tubing was attached to one end of a 3 cm PE 20 piece of
tubing (Fig. 18.13) using a modified 30 GA needle as a juncture (plastic hub is melted off
the 30 G needle) (Fig. 18.14). Just prior to the infusion procedure, the 75 cm tubing was
backfilled (from the PE 20 tubing to the infusion needle tip) with distilled water. The PE
20 tubing was attached to a microsyringe driver [Fig. 18.15 (Delsaga microdoser)] which
holds two lOpl Hamilton syringes (Fig. 18.16) that also have been previously filled with
distilled water. The drug was loaded into the tip of the infusion needles and the infusion
needles were inserted into the implanted cannula.

Figure 18. Implanted cannula, infusion needle and microsyringe driver, in detail.
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Appendix B: Home-Cage Behaviors
Behavior

Code

Description
State of the Rat

Asleep

6

Any position with eyes completely closed.

Awake

7

Any position with eyes partially or totally open.
Nonactive Behaviors of the Rat

Curled
Curled (buried)
Stretched

1

Lying or sitting with head bent over so spine is curved.

(1)
2

Same as “curled” but with head buried under the body.
Lying with belly touching the floor without curvature in the spine.

Tense sitting

3

Sitting with belly not touching the floor and front legs extended.

Relaxed sitting

4

Sitting with belly touching the floor, front legs tucked under body.

Motor Behavior

8

Change of position, designation given while eyes are closed
(asleep).
Active Behaviors of the Rat

Digging

D

Head or front paws moving corn-cob.

Eating

E

Smelling or eating food.

Grooming

G

Licking coat or paws, scratching, facial grooming with paws.

Jumping

J

All four legs not touching cage floor.

Motor Behavior

M

Walking or running.

Standing

S

Belly not touching the floor and all four paws on the floor.

Rearing

R

Body raised with front paws off cage floor.

Stretching

ST

Extension and stretching of body. Often accompanied by a yawn.

Startle

S!

Watering

W

Sudden and quick movement of body. Often accompanied by a
small vocalization.
Smelling or drinking from the water bottle.

Yawing

Y

Stretching mouth by opening and closing slowly.

Table 2. Nonactive and active home-cage behaviors, codes and descriptions.
Nonactive behaviors are always accompanied by an asleep or awake score.
Active behaviors are always accompanied by an awake score.
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